{
  "units": [
    {
      "title": "Methods",
      "text": "methods for primary then probed the AFEpC cluster for the presence of specific gastrointesfetal organoid derivation are destructive, restricting the use for tinal, kidney and lung signatures using single-cell gene set enrichment\nprenatal modeling, diagnostics and regenerative medicine21,22. Fur- analysis (scGSEA; Fig. 1d). Finally, we scored these cells for canonical\nthermore, fetal material can be procured mostly up to 20–22 weeks tissue-specific progenitor markers: LGR5, OLFM4, LRIG1, CDX2, CD44,\npost-conception, making investigation of later developmental stages LYZ, SMOC2 and PROCR (gastrointestinal); PAX2, PAX8, LHX1, JAG1,\nunfeasible23. Here we present derivation of primary human fetal epithe- SIX2, RET, HNF4A, GATA3, POU3F3 and WT1 (kidney); and NKX2-1, SOX9,\nlial organoids, of multiple tissue identities, obtained from fetal fluids ETV4, ETV5, GATA6 and ID2 (lung). This indicated the presence of gascollected at prenatal diagnostic and therapeutic interventions during trointestinal, renal and pulmonary epithelial progenitor cells in AF\nthe second and third trimesters. This allows generation of organoids (Fig. 1e).\nalongside continuation of pregnancy.\n Around 30,000 amniocenteses are performed annually in the Generation of primary fetal epithelial human AFOs\nUK24 for confirmatory diagnosis and advanced diagnostics2. Moreover, To investigate formation of AFOs we seeded viable AF cells in Matrigel\namniodrainage is routine treatment for polyhydramnios25,26 and TTTS27. droplets and cultured them in an ad hoc-defined generic epithelial\nFinally, prenatal MMC repair and fetoscopic endoluminal tracheal medium without tissue-specific signals (Supplementary Table 3). Indiocclusion (FETO) for CDH provide additional access to fetal fluids vidual AF cells began proliferating and self-organizing to form 3D orgaduring pregnancy3,4,6. The AF surrounds, supports and protects the noids, visible within 2 weeks. To establish clonal lines, individual AFOs\nfetus during development. Its origin and recirculation follow complex were picked, dissociated into single cells and replated (Fig. 2a,b and\ndynamics, progressing together with fetal and extra-embryonic tissue Extended Data Fig. 2a). Using this method, we derived 423 AFO lines from\ndevelopment. AF is highly heterogeneous in origin and composition, 42 AF samples (16–34 weeks gestational age (GA); Supplementary Tables 1\ncontaining secretions and cells from various fetal tissues such as the and 2). The clonal origin of AFOs was further confirmed by single-cell\ngastrointestinal tract, kidney and lung28,29; however, a detailed map AFEpC culture (Extended Data Fig. 2b). AFOs showed multiple morof the AF epithelial populations and their potential is lacking. AF har- phologies, expanded up to passage 20 and successfully cryopreserved,\nbors stem cells from mesenchymal and hematopoietic niches30–32 but providing evidence of self-renewal and long-term culture (Fig. 2c,d\nmost AF cells are epithelial and have only been partially characterized. and Extended Data Fig. 2b–e). Organoid formation was observed in\nUsing single-cell sequencing, we investigated human AF epithelial cells 89.7% of AF samples, with a median formation efficiency of 0.011% (one\n(AFEpCs), highlighting that these originate from multiple develop- organoid formed per 7.4 × 103 cells; Fig. 2b and Extended Data Fig. 2c).\ning tissues. We then explored whether this cell population contains We found no meaningful association between GA and AFO formation\nlineage-committed progenitors capable of forming tissue-specific efficiency. We imaged two distinct organoid morphologies through\nprimary fetal organoids. Additionally, we expanded our findings to tra- X-ray phase-contrast computed tomography (PC-CT), confirming the\ncheal fluid (TF) epithelial cells obtained from CDH cases during FETO33. applicability of the method for organoid characterization (Fig. 2e).\n This work demonstrates that diverse epithelial stem cell popula- Immunostaining confirmed cell proliferation (Ki67) and lack of apoptions shed into the AF and TF can form epithelial organoids resembling tosis (cleaved caspase 3) within AFOs (Fig. 2f). We confirmed the AFO’s\ntheir tissue of origin. Autologous derivation of primary fetal orga- epithelial identity by staining for pan-epithelial markers (EpCAM, ECAD\nnoids during continuing pregnancies could enable the development and pan-cytokeratin) and showing absence of the mesenchymal marker\nof advanced prenatal models and improve counseling and designing platelet-derived growth factor receptor α (PDGFRα). Notably, AFO’s\npersonalized therapies. Finally, AF organoids (AFOs) offer the possibil- epithelium is polarized as demonstrated by basolateral integrin β4\nity of researching later gestational stages currently inaccessible, being (ITGβ4), apical F-actin and zonula occludens-1 (ZO-1)-positive luminal\nbeyond the limits of termination of pregnancy. tight junctions (Fig. 2g).\n\nrepresentation of AF sampling. Bottom left: the FACS plot shows the sorting markers, within the epithelial cluster identified in a. c, Representative flow\nstrategy utilized to collect the living cell fraction, negative for propidium iodide cytometry analysis of EpCAM (n = 58,964 cells) and ECAD (CDH1, n = 38,389 cells)\n(PI) and positive for Hoechst. Middle: the UMAP shows the content of the AF of expression in live-sorted cells from the AF; gray represents unstained control\nmultiple patients obtained across the second and third trimesters of pregnancy (n = 34,045 cells). d, Re-calculated UMAP of the epithelial cluster identified in a,\n(n = 12 biologically independent AF samples spanning 15–34 GA; 33,934 cells highlighting cells attributed to the three tissues through scGSEA. e, Scoring of\npost-filtering examined over 11 sequencing lanes). Highlighted in orange is the the cells identified in d, for appropriate progenitor-associated genes. Cells with\nepithelial cluster, as identified by the SingleR cell-labeling package using the a positive score are highlighted on a re-calculated UMAP of that tissue’s cells.\nhuman primary cell atlas dataset as reference. Right: the violin plots show the Scores also plotted as violin plots, identifying distinct populations of progenitor\nlevel of expression of the pan-epithelial specific genes EPCAM, CDH1(ECAD), cells, threshold for positive scoring shown in red.\nKRT8, KRT10, KRT17 and KRT19 (mean ± s.d., data presented as normalized counts\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n We then conducted bulk RNA sequencing to investigate the tissue lung (n = 6), kidney (n = 4), bladder (n = 1) and placenta (n = 1; Fig. 1e).\nidentity of each clonal AFO line. As a control, we isolated tissue-derived Unsupervised principal-component analysis (PCA) conducted on bulk\nhuman organoids from fetal small intestine (n = 5), stomach (n = 3), RNA-seq data (n = 121 AFOs, 23 AF samples; Supplementary Table 2)\n\n a Epithelial marker\n SingleR-labeled\n epithelial cells expression\n\n EPCAM\n Macrophages\n\n Neutrophils CDH1\n\n 12 samples\n (15–34 GA) KRT8\n B cells\n\n KRT10\n NK-cells\n\n Monocytes KRT17\n Dead cells\n\n Epithelial\n\n T cells KRT19\n UMAP 2\n\n UMAP 1 Erythroblasts 0 2 4 6 8\n Nucleated cells\n\n b c EpCAM\n EPCAM CDH1 KRT8 100\n\n 0\n –103 0 103 104 105\n ECAD (CDH1)\n 100\n logNormalized\n\n 4\n\n 3\n CPM\n\n 2\n\n 0\n –103 0 103 104 105\n\n d Gastrointestinal epithelia Kidney epithelia Lung epithelia\n\n e Gastrointestinal progenitors Kidney progenitors Lung progenitors\n\n 0.4 0.4\n 0.6\n Progenitors\n Progenitors\n Progenitors\n\n 0.2 0.2\n 0.3\n\n 0 0 0\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nshowed three AFO clusters colocalizing with small intestinal, pul- peptidase IV (peptide hydrolysis; Fig. 3g) and disaccharidase (sucrose\nmonary and renal fetal tissue-derived control organoids (Fig. 2h and hydrolysis; Fig. 3h). Finally, to investigate the potential of SiAFOs for tis-\nor stomach organoids, whereas one AFO clustered with the placental Three hours after seeding, SiAFOs started fusing; by day 2 a more comcontrol. Cluster-based Gene Ontology analysis corroborated the single plex tubular budding structure had formed with full ring maturation\ntissue identity of each AFO clone, showing upregulation of pathways at day 10. MicroCT revealed SiAFO ring self-organization, forming a\nspecific to the assigned tissues (Extended Data Fig. 2g). Annotation was tube-like structure with lumen and buddings resembling intestinal\nfurther confirmed by Euclidean hierarchical clustering (Extended Data architecture (Fig. 3j, Extended Data Fig. 3e and Supplementary Video 1).\nintestine n = 3, kidney n = 6 and lung n = 4; Supplementary Table 2) tight junctions (ZO-1), in addition to enterocytes (FABP1 and KRT20),\nhighlighted multiple epithelial cell clusters (Fig. 2i). Overall, this pro- enteroendocrine (CHGA), Paneth (LYZ) and goblet secretory cells\nvides evidence that intestinal, renal and pulmonary AFEpCs can give (MUC2). Moreover, SiAFO rings maintained proliferation (Ki67) in the\nrise to clonal AFO lines reflecting their respective tissue of origin. crypt-like portion (Fig. 3k, Extended Data Fig. 3f and Supplementary\n Video 2). The overall marker profile of SiAFO rings (bulk RNA-seq in\nCharacterization and maturation of SiAFOs Fig. 3b), revealed strong upregulation of genes typical of functionally\nSmall intestinal AFOs (SiAFOs) expanded consistently for more than differentiated intestinal cells, particularly of mucin secretory lineages,\nten passages, forming crypt-like structures (Fig. 3a and Extended Data brush border enzymes and enterocytes.\nof 23 SiAFOs showed expression of typical intestinal stem/progenitor Kidney tubule AFOs (KAFOs) expanded long-term (up to passage\n(LGR5, OLMF4, LRIG1 and SMOC2), Paneth (LYZ), goblet (MUC2 and 10), while maintaining proliferation (Ki67; Fig. 4a and Extended Data\nCLCA1), endocrine (CHGA) and enterocyte (ALPI, FABP1, VIL1, EZR, Fig. 4a) and mostly manifested a compact morphology with several\nKRT20 and ATP1A1) markers (Fig. 3b). Immunostaining for the stem lines showing a cystic structure. Bulk RNA-seq of 54 KAFOs (19 AF samcell marker olfactomedin 4 (OLFM4) and intestinal epithelial cytokera- ples; 18–34 weeks GA) showed expression of canonical developmentin 20 (KRT20) confirmed the presence of a crypt–villus axis. SiAFO tal renal epithelial and nephron progenitor genes (PAX2, PAX8, LHX1\nimmunostaining showed markers of numerous intestinal cell types and JAG1), while lacking cap mesenchyme markers (SIX2, CITED1 and\n(Fig. 3c,d) such as Paneth cells (lysozyme (LYZ)) and enterocytes (fatty GDNF). Moreover, we detected distal (PCBD1, SLC41A3 and POU3F3)\nacid-binding protein 1 (FABP1)). Notably, SiAFOs lack lung (NKX2-1) and and proximal (ABCC1, ABCC3, ABCC4 and CUBN) tubule gene expreskidney (PAX8)-specific markers (Extended Data Fig. 3b). scRNA-seq sion. Collecting duct marker GATA3 was expressed, while the loop of\nconfirmed the presence of tissue-specific cellular identities such as Henle marker UMOD was not. Podocyte markers (WT1, NPHS1 and\nintestinal stem cells, proliferating transit amplifying, enterocytes, NPHS2) were not expressed in KAFOs except PODXL and MAFB (Fig. 4b\ngoblet and enteroendocrine cells (Fig. 3e). and Extended Data Fig. 4b). Based on this, we concluded that KAFOs\n We then performed a maturation assay culturing SiAFOs in have a tubuloid-like phenotype and express markers belonging to\nintestinal-specific medium for 14 d. Upon maturation, SiAFOs dis- different renal tubule segments, confirmed by protein expression\nplayed more prominent budding structures, resembling small of PAX8 and LHX1. KAFOs also displayed the segment-specific kidintestinal crypt-like organization. Immunofluorescent (IF) staining ney tubule proteins GATA3 and ECAD (distal tubule/collecting duct).\nshowed chromogranin A (CHGA)-positive enteroendocrine cells and Conversely, we detected LTL, representing proximal tubule identity.\nstronger presence of goblet cell marker mucin 2 (MUC2) compared Of note, KAFOs exhibited a mixed tubular phenotype, coexpressto pre-maturation (Fig. 3f and Extended Data Fig. 3c). In addition, ing GATA3 and LTL or presenting only GATA3. The presence of polarquantitative reverse transcription PCR (RT–qPCR) following DAPT ized tubular microvilli was validated by immunofluorescence for\ntreatment demonstrated downregulation of Notch target genes (HES1 acetylated tubulin (Ac-αTUB) (Fig. 4c,d and Extended Data Fig. 4c).\nand OLFM4), stem/progenitor cells, Paneth cells and Wnt target genes Additionally, KAFOs showed increased intracellular thallium fluo-\n(LGR5, LYZ and AXIN2). While enterocyte and goblet cell markers (FABP1, rescence compared to fetal lung organoids (FLOs), comparable to\nALPI and MUC2) were upregulated, the enteroendocrine marker CHGA control fetal kidney organoids (FKOs), indicating the presence of\nwas not. Notably, Notch inhibition did not drive increased expression functional voltage-gated potassium channels (Fig. 4e). Moreover,\nof ATOH1 nor its downstream target DLL1 (Extended Data Fig. 3d). KAFOs display functional epithelial tight junctions, with apical ZO-1\n To evaluate SiAFO functional capacity, we assessed the diges- (Extended Data Fig. 4d) and intact barrier integrity with 67.9% of\ntive activity of two small intestinal brush border enzymes, dipeptidyl KAFOs impermeable to inulin-FITC diffusion, decreased to 24.4%\n\nshowing organoid formation from 3D cultured viable AF cells, with different in AFOs at P3; nuclei counterstained with Hoechst (scale bars, 50 μm).\norganoid morphologies observed at day 14 (scale bar, 200 μm). b, Top: formation g, Immunofluorescent staining showing AFO at P3 expressing the epithelial\nefficiency (organoids per live cells) and size (organoid area) of AFOs at isolation markers EpCAM, ECAD and pan-cytokeratin, while lacking expression of the\n(passage (P) 0) (n = 26 independent AF samples for efficiency plot and n = 197 mesenchymal marker PDGFRɑ. Immunofluorescent staining also shows AFO\norganoids for area plot; median and quartiles for both plots). Bottom: linear polarization, highlighted by the presence of the epithelial tight junction ZO-1 on\nregression plot representing organoid formation efficiency (organoids per the luminal surface and basolateral ITGβ4. Phalloidin counterstain highlights\nlive cells) at various GAs. Color and size represent the total organoid number actin filaments (F-ACT) (scale bars, 50 μm). h, Unsupervised PCA plot showing\ngenerated per sample; dashed line represents linear regression, R2 = 0.05 and AFOs (triangles) forming three main clusters (n = 121 organoid lines from n = 23\ns.e.m. is shown in gray. c, Phase-contrast images showing multiple clonal AFO AF samples). These clusters show colocalization with primary fetal tissue-derived\nmorphologies in expansion, at P1, P5, P10 and up to P20 (scale bars, 200 μm). control organoids (circles, n = 20) produced from lung (cyan), small intestine\nd, Formed organoids per mm2 at 7–15 d of culture quantified over ten passages (purple), kidney (green), placenta (yellow), bladder (orange) and stomach (red)\n(n ≥ 11 organoids from n = 19 independent AF samples; median and quartiles; samples. i, scRNA-seq UMAP produced from representative AFOs from the three\nNS, non-significant; one-way analysis of variance (ANOVA) with multiple tissue identities. Epithelial cells are highlighted in orange, as identified by the\ncomparison). e, X-ray PC-CT of two organoid phenotypes observed (compact and SingleR cell-labeling package; KAFOs (1,467 cells, n = 5 patients), LAFOs\ncystic). Scale bars, 25 μm. f, Immunofluorescent staining showing expression of (1,966 cells, n = 4 patients) and SiAFOs (1,576 cells, n = 2 patients) are shown.\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nupon ethylenediaminetetraacetic acid (EDTA) treatment (Fig. 4f and ureteric tip/stalk and distal tubule or early nephron and nephron pro-\non KAFOs confirmed the presence of multiple renal tubule cells such as ureteric bud marker RET (Fig. 4b and Extended Data Fig. 4b). RET\n\n a P0 isolation b\n 0.04\n\n Organoid area (µm2)\n Organoid formation\n 106\n\n efficiency (%)\n 0.03\n 105\n 0.02\n\n 0.01 104\n\n 0\n AFO AFO\n c P1 0.05 R2 = 0.05\n\n Organoid formation\n No. of organoids generated\n 20\n 0.04\n\n efficiency (%)\n 50\n 0.03 80\n\n 0.02\n 0.01\n\n P5 0\n\n 16 20 25 30 34\n GA (weeks)\n\n d NS\n 50\n\n organoids per mm2\n 40\n P10 P20\n\n Formed\n 30\n\n 20\n\n 10\n\n 0\n P1 P2 P3 P5 P10\n e f g\n Ki67 + EpCAM Nuclei ITGβ4 ZO-1 Nuclei\n Compact Nuclei\n\n c-Casp3 ECAD PDGFRα F-ACT panCK Nuclei\n Nuclei Nuclei\n Cystic\n\n h i\n 100\n Small intestine\n\n SI10w\n 50 SI18w\n K22wA SI14w\n SI13w Epithelial cells\n K22wB K14w\n SI23w\n PC2: 13% variance\n\n K16w\n P14w\n scRNA-seq\n\n 0 Classification\n Kidney\n\n B14w Bladder\n S13w S22w\n L11w S20w Kidney\n Lung\n L20w L18w Placenta\n −50 L16w Small intestine\n L14w L23w\n Stomach\n\n Derivation\n Lung\n\n AF-derived organoids\n −100\n Fetal tissue-derived control organoids\n\n −100 −50 0 50 100 150\n PC1: 23% variance\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\na P0 P1 P10 P5 b Fetal tissue-derived Mature\n organoid controls SiAFO SiAFO SiRings\n EdU Nuclei log(CPM)\n OLFM4\n 0 LGR5\n 2 LRIG1\n 6 SMOC2 Stemness\n 8 BMI1\n HOPX\n PROCR\n Relative CDX2 Progenitor\n expression LYZ Paneth\n 1.0 MUC2\n Goblet\n CLCA1\n\nc OLFM4 ITGβ4 LYZ Nuclei FABP1 ECAD Nuclei\n d 0.5\n CHGA\n SYP\n Enteroendocrine\n\n cells per organoid (%)\n 25 DCLK1\n KRT20 Tuft\n 20 TRPM5\n 0 ALPI\n\n Positive\n 15 FABP1\n VIL1\n 10 Enterocytes\n EZR\n 5 KRT20\n ATP1A1\n 0 MUC1\n MUC3A\n MUC13 Differentiated\n\n 4\n Z\n U\n LY\n M\n\n Ed\n MUC17 villi\n\n LF\ne f\n\n O\n MUC20\n CDH17\n Maturation CYBRD1\n Duodenum\n SLC40A1\n CHGA F-ACT MUC2 Nuclei SI\n Nuclei Jejunum\n LCT\n SLC10A2\n Ileum\n Stem cells OSTB\n PRAC1\n CHGA+ EE SATB2 Colon\n MKI67 Proliferation\n EPCAM Epithelium\n Enterocytes PDGFRA Mesenchymal\n\n 10GA\n 13GA\n 14GA\n 18GA\n 23GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 17GA\n 16GA\n 16GA\n 16GA\n 16GA\n 16GA\n 17GA\n 16GA\n 16GA\n 17GA\n 17GA\n 17GA\n Proliferative TA\n\n Maturation\n i j k\n Goblet\n Expansion Day 0 Day 2 Day 10 KRT20 ITGβ4 LYZ ZO-1\n CHGA Nuclei\n Nuclei\n\ng Dipeptidyl peptidase IV h Disaccharidase L *\n Pt 1 no. 1 +PBS +Sucrose\n 30\n Glucose nmol per min per mg\n\n Pt 1 no. 2 8\nNitroaniline per mg protein\n\n protein (nmol min–1 mg–1)\n\n Pt 1 no. 3\n Pt 1 no. 5\n Pt 2 no. 1 6\n 20 CT (ileal)\n **** FABP1 MUC2 Ki67 F-ACT\n ***\n (µg mg–1)\n\n Relative perimeter (%)\n\n 4 100 Nuclei Nuclei\n\n 10 2\n 50 L *\n PBS 0\n 0 L\n 20 40 60 0\n O\n\n O\n\n l)\n ea\n AF\n\n AF\n\n h\n h\n h\n 21 h\n h\n\n Time (min)\n (il\n\n 0\n 3\n 24\n 72\n 6\n Si\n\n Si\n\n T\n C\n\ncontrast images depicting SiAFO expansion (scale bar, 200 μm). EdU assay clonal organoid lines at P6 and P10; n = 1 pediatric small intestinal ileal organoid\nshowing proliferating cells localized at the crypt-like structure bases (scale control; mean ± s.e.m.). h, Functional evaluation of disaccharidase activity (n = 2\nbar, 50 μm). b, RNA-seq dot plot showing presence of small intestine markers independent biological samples; n = 3 clonal organoid lines; n = 1 pediatric small\nin SiAFOs (n = 2 independent biological samples, n = 23 lines in expansion, intestinal ileal organoid control; mean ± s.e.m.). i,j, Schematic (created using\nn = 6 mature lines, n = 5 rings, n = 5 control fetal tissue-derived small intestinal BioRender) (i) and phase-contrast images (j, top) showing self-assembly and\norganoids). c, Immunofluorescence for intestinal stem cell marker OLFM4, compaction of SiAFO ring (scale bars, 200 μm, 1 mm and 500 μm for insets; n = 8\nenterocyte marker KRT20 and ITGβ4. Paneth cells and enterocytes are rings from two AFs). Quantification of the ring’s relative perimeter over time\nhighlighted by LYZ, FABP1 and ECAD staining (scale bars, 50 μm). (n = 4 independent experiments; mean ± s.e.m.; ***P = 0.002, ****P < 0.0001,\nd, Quantification of OLFM4, LYZ and EdU in SiAFOs (n = 2 independent biological one-way ANOVA multiple comparisons). MicroCT 3D reconstructions and\nsamples; ≥4 organoids per sample; mean ± s.e.m.). e, Annotated scRNA-seq UMAP cross-sections of a whole SiAFO ring depicting luminal structure (j, bottom)\nof representative SiAFOs in expansion (gray; 1,576 cells, n = 3 organoid lines) (scale bar, 50 μm). L, lumen. k, SiAFO rings display a lumen and KRT20-positive\nand maturation (orange; 1,666 cells, n = 3 organoid lines). f, Matured SiAFOs enterocytes, with ITGβ4 highlighting the basal side along with CHGA-positive\nshow budding morphology (scale bar, 200 μm). Immunofluorescent staining enteroendocrine cells. The panel displays LYZ-positive cells, ZO-1-positive tight\ndisplays CHGA-positive enteroendocrine cells and MUC2-positive secretory junctions, FABP1-positive enterocytes and MUC2 secretory cells in the SiAFO ring;\ncells. Counterstain with phalloidin (F-ACT) and Hoechst shows organoids’ proliferating Ki6-positive cells are observed in the crypt-like domain (*, external\nlumen and nuclei, respectively (scale bars, 50 μm). g, Functional assessment side) (scale bars, 50 μm). CT, control; PBS, phosphate-buffered saline.\n\nprotein staining on the luminal side presented comparably to fetal kid- Characterization and differentiation of LAFOs\nney sections and FKOs. (Fig. 4h and Extended Data Fig. 4f). In addition, Lungs are major cellular contributors to AF, continuously releasing\n85.7% of RET-expressing KAFO lines exhibited compact morphology, fluid into the amniotic cavity. Consequently, lung AFOs (LAFOs) formed\nthis decreased to 54.5% in RET-negative lines, exhibiting more cystic or from the majority of our samples. We isolated, clonally expanded and\nmixed morphology (Fig. 4i). Finally, we adapted a reported protocol sequenced 43 LAFO lines from 12 AF samples spanning 16–34 weeks GA.\nto differentiate KAFOs toward a distal/collecting duct phenotype. LAFOs were propagated up to 21 passages maintaining high prolifera-\nAfter 14 d of vasopressin and arginine-aldosterone stimulation, KAFOs tion, confirmed by Ki67 staining (Fig. 5a and Extended Data Fig. 5a).\nmanifested markers of the collecting duct (AQP2) and distal tubules LAFOs can have cystic or compact morphology (Extended Data Fig. 5b,c).\n(SLC12A1 and CALB1), which were lower in expansion medium (Fig. 4j Bulk RNA-seq indicated expression of multiple pulmonary markers in\nand Extended Data Fig. 4g). Additionally, differentiated KAFOs dis- 43 LAFOs, manifesting stem/progenitor cell markers (NKX2-1, FOXA2,\nplayed more CALB1-positive cells upon immunostaining (21 ± 6.6%) SOX2, SOX9, TP63 and GATA6), alveolar type 1 (HOPX, PDPN, AGER and\nand increased CALB1 gene expression (Fig. 4k). AQP5) and alveolar type 2 cell-related genes (SFTPA1, SFTPA2, SFTPB,\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n a P0 P1 P10 P5 b log(CPM) Relative expression\n 0 2 4 6 1 0.5 0\n Ki67 Nuclei\n Fetal tissue-derived Differentiated\n organoid controls Kidney tubule AFO KAFO\n SOX9 Stemness\n PROM1\n PAX8\n PAX2 Nephron\n LHX1 progenitor\n JAG1\n SIX2\n CITED1 Cap\n GDNF mesenchyme\n\n c PAX8 F-ACT LHX1 F-ACT GATA3 LTL ECAD Ac-αTUB Nuclei\n RET\n WNT11 Ureteric bud\n FGF9\n AQP2\n AQP3\n SLC4A1\n GATA3 CD\n FOXI1\n SLC26A4\n ATP6V1B1\n CDH1 CD and DT\n CALB1\n SLC12A3\n PCBD1 DT\n\n d e f Inulin-FITC\n SLC41A3\n POU3F3\n SLC12A1 DT and LoH\n *\n\n intact barrier integrity (%)\n 1.0\n *\n K+ ion channel activity\n\n 100 UMOD\ncells per organoid (%)\n\n 100 LoH\n NS\n –EDTA\n\n CLDN10\n MFI per cell (a.u.)\n\n 0.8\n\n Organoids with\n 80 CLDN14\n 75 LRP2\n 0.6\n Positive\n\n 60 CUBN\n 50 AQP1\n 0.4 40 VIL1\n 25 ABCB1\n +EDTA\n\n 0.2\n 20 ABCC1 Proximal tubule\n 0 0 ABCC3\n 0 ABCC4\n SLC22A3\n A3\n\n FO\n\n O\n X8\n\n O\n G X1\n\n 67\n\n A\n\n A\n SLC22A8\n FK\n\n FL\n LH\n\n Ki\n PA\n\n AT\n\n KA\n\n DT\n\n DT\n –E HNF4A\n\n +E\n WT1\n g h RET + KAFO RET – KAFO\n NPHS1\n NPHS2 Podocyte\n PODXL\n RET Nuclei MAFB\n Early nephron MKI67 Proliferation\n EPCAM Epithelium\n NPC PDGFRA Mesenchymal\n\n 14GA\n 16GA\n 22GA\n 22GA\n 18GA\n 21GA\n 21GA\n 21GA\n 22GA\n 22GA\n 22GA\n 22GA\n 22GA\n 22GA\n 23GA\n 24GA\n 24GA\n 24GA\n 24GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 27GA\n 27GA\n 27GA\n 27GA\n 27GA\n 27GA\n 28GA\n 28GA\n 29GA\n 29GA\n 30GA\n 31GA\n 34GA\n 22GA\n 24GA\n 25GA\n 25GA\n 27GA\n 27GA\n 27GA\n Ureteric\n stalk GA (weeks)\n\n i Cystic\n j\n Early DT Mixed\n Compact\n k CALB1 CALB1\n\n * **\n Percentage of organoids\n\n 100 AQP2 Nuclei SLC12A1 F-ACT CALB1 Nuclei 40 1 × 104\n\n cells per organoid (%)\n Nuclei\n\n Expression (CPM)\n Differentiation\n\n DT 75 30 1 × 103\n\n Positive\n 1 × 102\n 50 20\n Ureteric Differentiation\n 1 × 101\n tip/stalk Expansion 25 10\n 1 × 100\n 0 0 1 × 10–1\n T +\n\n T –\n\n FF\n\n FF\n T\n\n T\n C\n\n C\n RE\n RE\n\n DI\n\n DI\na, Phase-contrast images showing long-term KAFO culture (scale bar, 200 μm). n = 5 independent biological samples; mean ± s.e.m.; *P = 0.0121, two-tailed\nImmunofluorescent staining highlights proliferative marker Ki67 (scale bar, paired t-test). g, Annotated KAFO scRNA-seq UMAP in expansion (gray; 1,467 cells,\n50 μm). b, Bulk RNA-seq showing broad kidney markers’ presence in KAFOs n = 6 KAFO lines) and differentiation (orange; 3,559 cells, n = 3 KAFO lines). NPC,\n(n = 19 independent biological samples, n = 37 lines in expansion, n = 7 lines in nephron progenitor cells. h, Immunofluorescent staining showing RET protein\ndifferentiation medium, n = 4 control FKOs). CD, collecting duct; DT, distal tubule; localization in RET+ and RET− KAFOs (scale bars, 50 μm). i, Stacked bar chart\nLoH, loop of Henle. c, Immunofluorescent staining shows presence of nephron representing proportion of organoids with compact, cystic, or mixed (compact/\nprogenitor markers PAX8 and LHX1 counterstained with phalloidin (F-ACT) cystic) morphology in RET+ and RET− KAFOs (*P = 0.0255, Spearman rank test).\nand positivity for distal tubule/collecting duct marker GATA3, proximal tubule j, Phase-contrast and immunofluorescent (IF) images highlighting morphological\nmarker LTL, ECAD and Ac-αTUB apical cilia, further confirming the renal epithelial changes, as well as the expression of the mature renal markers AQP2, SLC12A1\nidentity of KAFOs (scale bars, 50 μm). d, Quantification of renal markers PAX8, and CALB1 in KAFOs upon differentiation (scale bars, 200 μm phase-contrast\nLHX1, and GATA3 in KAFOs (n = 6 independent biological samples, ≥4 organoids and 50 μm IF). k, Left: quantification of CALB1-positive cells in KAFOs cultured in\nper sample; mean ± s.e.m.). e, Potassium ion channel assay performed on n = 7 expansion (CT) and differentiation (DIFF) medium (n = 4 independent biological\nKAFOs from independent biological samples, n = 3 FKOs, n = 3 FLOs as negative samples, mean ± s.e.m.; *P = 0.0357, two-tailed paired t-test). Right: CALB1 gene\ncontrol (mean fluorescence intensity (MFI) was calculated; mean ± s.e.m., one-way expression in differentiated KAFOs (DIFF) compared to undifferentiated controls\nANOVA with multiple comparisons; *P = 0.0393). f, Images showing inulin assay (CT) based on the RNA-seq plot presented in b (n ≥ 6 differentiated independent\nresults from untreated and EDTA-treated KAFOs (scale bars, 50 μm); percentage biological samples; mean ± s.e.m.; **P = 0.0029, unpaired t-test).\n\nSFTPC, SFTPD, ABCA3 and LAMP3). Mature basal cell markers KRT5, NKX2-1 and SOX2 and basal cell marker P63 (Fig. 5c,d). Pro-surfactant\nTROP2 and NGFR were rarely detected in LAFOs as well as the ciliated protein C (proSFTPC) was absent (Extended Data Fig. 5e).\ncell transcription factor FOXJ1, which showed sporadic low expression We then investigated the proximal and distal differentiation of\nin the expansion medium. Furthermore, the early secretory cell marker LAFOs. scRNA-seq indicated successful proximal airway differentia-\nSCGB3A2 was highly expressed compared to the absent mature club cell tion with newly formed specialized cell clusters such as ciliated and\nmarker SCGB1A1. Secretory goblet cell marker MUC5AC was expressed deuterosomal cells, associated with an increase in secretory cells\nin tissue-derived control FLOs, but several LAFO lines showed low/negli- (Fig. 5e; top UMAP). Notably, we also observed polarized epithelium\ngible expression. Last, while the neuroendocrine cell marker ASCL1 was with motile cilia on LAFO luminal surfaces (Supplementary Video 3).\nexpressed in almost all LAFOs, only a small number showed expression Immunofluorescent staining confirmed the presence of luminal\nof CHGA (Fig. 5b and Extended Data Fig. 5d). Immunostaining dem- Ac-αTUB cilia on proximally differentiated LAFOs, which was further\nonstrated homogenous protein expression of the stem cell markers corroborated by ciliated epithelia marker FOXJ1 nuclear expression\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\na P0 P1 P10 P5 b\n log(CPM) Relative expression\n Ki67 Nuclei 0 2 4 8 12 1 0.5 0\n Fetal\n tissue-derived\n organoid controls Lung AFO Differentiated LAFO\n\n SOX2\n SOX9\n ETV4\n ETV5 Stemness\n ID2\n GATA6\n MSX2\n NKX2−1\nc d\n Progenitors\n FOXA2\n TP63\n NKX2-1 SOX2 P63\n\n cells per organoid (%)\n 100 KRT5\n F-ACT F-ACT F-ACT TROP2 Basal\n 75 NGFR\n\n Positive\n MYCN\n 50 SCGB1A1\n SCGB3A2 Secretory\n 25 MUC5AC\n MUC5B\n 0 FOXJ1\n DNAI2 Ciliated\n\n SO 1\n X2\n\n 3\n 67\n 2-\n\n P6\n Ki\n TUBA1A\n\n KX\n N\n ASCL1\n Neuroendocrine\ne f CHGA\n AQP5\n Neuroendocrine Alveolar\n P63 Ac-αTUB FOXJ1 KRT5 MUC5AC SOX2 HOPX\n type 1\n Deuterosomal Hillock− PDPN\n Ciliated like\n AGER\n Proximal LAFO\n\n Progenitors\n SFTPA1\n AT2 SFTPA2\n prolif.\n LAP SFTPB\n AT2 Alveolar\n SFTPC\n AT2 type 2\n diff. SFTPD\n Club ABCA3\n Basal\n Proximal LAMP3\n Expansion SLC34A2\n Proliferation\n MKI67\n Neuroendocrine\n g h EPCAM\n Epithelium\n\n **** **** ***\n Mesenchymal\n Deuterosomal Hillock− FOXJ1 CT PDGFRA\n Ciliated\n **\n like 1 × 104 Prox diff\n 100\n Expression (CPM)\n\n 11GA\n 14GA\n 16GA\n 18GA\n 20GA\n 23GA\n 16GA\n 17GA\n 20GA\n 21GA\n 23GA\n 23GA\n 23GA\n 24GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 25GA\n 27GA\n 27GA\n 27GA\n 30GA\n 34GA\n 34GA\n 34GA\n 16GA\n 17GA\n 20GA\n 21GA\n 23GA\n 25GA\n 25GA\n 16GA\n 17GA\n 20GA\n 21GA\n 23GA\n 25GA\n 25GA\n NS NS\n Positive cells per\n\n Progenitors 1 × 103\n AT2 80\n organoid (%)\n\n prolif.\n LAP 60 1 × 102\n AT2\n\n al\n\n al\n im\n\n st\n AT2 1 × 101 GA (weeks)\n\n Di\n 40\n\n ox\n diff.\n\n Pr\n Club 20 1 × 100\n Distal Basal\n\n 0 1 × 10–1\n Expansion\n CT DIFF FOXJ1 TUB1A1 SCGB1A1 MUC5AC KRT5\n Ciliated Club Goblet Basal\n\ni j k l\n SFTPB Nuclei SFTPB F-ACT Nuclei 1 × 106\n * ** * NS CT\n Dist diff\n Expression (CPM)\n\n 1 × 105\n 1 × 104\n Distal LAFO\n\n 1 × 103 *\n * 1 × 102\n 1 × 101\n 1 × 100\n 1 × 10–1\n SFTPA1 SFTPA2 SFTPB SFTPC SFTPD\n *\n\nimages depicting LAFO expansion (scale bar, 200 μm). IF staining highlights TUBA1A, SCGB1A1, MUC5AC and KRT5 in proximal LAFOs (DIFF) compared to\nproliferative marker Ki67 (scale bar, 50 μm). b, Dot plot showing representative undifferentiated controls (CT) based on the RNA-seq plot presented in b (n ≥ 7\nbulk RNA-seq gene expression in LAFOs (n = 12 independent biological samples, independent biological samples; median and quartiles; SCGB1A1 ***P = 0.0003,\nn = 21 undifferentiated LAFOs, n = 14 differentiated LAFOs, n = 6 control FLOs). ****P < 0.0001, Holm–Šídák multiple unpaired t-test). i, TEM images showing\nc, IF staining highlighting the presence in LAFOs of lung stem/progenitor cell proximal LAFOs with cilia inside the lumen (asterisk) (scale bar, 2 μm); in crossmarkers NKX2-1 and SOX2 together with P63 basal cells; counterstaining with section, axonemes showing outer (red arrow) and inner (white arrow) dynein\nphalloidin (F-ACT) (scale bars, 50 μm). d, IF quantification (n = 6 AF samples, arms (scale bar, 100 nm). j, Distalized LAFOs showing surfactant-secreting cells\n≥4 organoids per sample; mean ± s.e.m.). e, Annotated scRNA-seq UMAPs of (SFTPB) with granular and luminal secretion; Hoechst-counterstained nuclei\nLAFOs in expansion (gray; 1,966 cells, n = 4 organoid lines), proximal (top; (scale bars, 50 μm). k, Violin plot showing surfactant-related gene expression in\n3,371 cells, n = 3 organoid lines) and distal differentiation (bottom; 1,351 cells, distalized LAFOs (DIST DIFF) compared to control in expansion (CT) based on the\nn = 3 organoid lines). f, IF staining on proximally differentiated LAFOs reveals RNA-seq plot presented in b (n ≥ 7 independent biological samples; median and\npolarized expression of ciliary protein Ac-αTUB, and ciliated cell marker FOXJ1. quartiles; NS, non-significant; SFTPA1 *P = 0.0107, SFTPA2 **P = 0.0002, SFTPB\nThe panel also shows expression of basal cell markers P63, KRT5, presence of *P = 0.0168, SFTPD *P = 0.0028, Holm–Šídák multiple unpaired t-test). l, Left:\nmucin 5AC goblet cells and maintenance of SOX2 progenitor cells (scale bars, TEM of distalized LAFOs showing lumen (*) and cells containing lamellar bodies\n50 μm). g, Quantification of FOXJ1-positive cells within LAFOs in expansion (CT) (red arrows). Right: magnification of lamellar body containing multi-lamellar\nversus proximal differentiation (DIFF) (n = 5 independent biological samples, membranes. Scale bars, 1 μm and 500 nm, respectively.\n≥4 organoids per sample; mean ± s.e.m.; **P = 0.0016, two-tailed paired t-test).\n\n(Fig. 5f). In addition, the appearance of keratin 5 (KRT5; mature basal SCGB1A1, when compared to undifferentiated controls (Fig. 5h). Cilia\ncells) and secretory marker mucin (MUC5AC) concomitantly with the were analyzed in detail by transmission electron microscopy (TEM),\nmaintenance of SOX2, corroborated proximal lung differentiation displaying normal rootlets with associated mitochondria. The ciliary\n(Fig. 5f and Extended Data Fig. 5f). FOXJ1-positive cells (62.8 ± 8.2%) axonemes also displayed normal structures with radial spokes and a\nincreased in the differentiated LAFOs compared to controls in expan- normal central microtubule pair, outer and inner dynein arms (Fig. 5i\nsion, whereas the number of KRT5-positive cells (3.8 ± 2.2%) did not and Extended Data Fig. 5g). When directed toward a distal phenotype,\n(Fig. 5g and Extended Data Fig. 5f). Moreover, proximal LAFOs showed LAFOs increased protein expression of the AT2 marker SFTPB, displayincreased gene expression of airway markers such FOXJ1, TUBA1A and ing different cellular localization in independent LAFO lines. Some\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\npresented within intracellular granules, others as luminal surfactant between CDH and GA-matched control LAFOs showed a reduction in\naccumulation, possibly indicating a more mature state (Fig. 5j and differentially expressed genes (DEGs) (P < 0.01, logfold change (FC) > 2)\nSFTPA2, SFTPB and SFTPD (Fig. 5k). Notably, scRNA-seq revealed that FETOs (Fig. 6i, with further comparisons shown in Extended Data Fig. 8).\ndistally differentiated LAFOs showed increased SCGB3A2+/SFTPB+ Gene Ontology analysis identified upregulated pathways related to\nlower airway progenitor cells, emergence of a Hillock-like cluster and surfactant production and metabolism in CDH organoids, upregulation\nreduction of club cells (Fig. 5e; bottom UMAP). Finally, ultrastructural of phosphatidylcholine metabolism, and downregulation of pathways\nanalysis revealed that distal LAFOs contain lamellar bodies with a nor- related to laminin interaction, integrin/ECM interaction and ECM promal structure, typical of surfactant-secreting cells (Fig. 5l). Overall, this teoglycans (P < 0.05, logFC > 1), more evident in post-FETO organoids\nindicates progression of LAFOs toward more mature lung phenotypes. (Extended Data Fig. 6f,g). SFTPC expression was also validated through\n immunofluorescent staining (Fig. 6j).\nCharacterization of AF and TF organoids from CDH fetuses We then differentiated CDH LAFOs/LTFOs. Similar to controls,\nCDH is a rare congenital malformation where the diaphragm fails to proximal CDH LAFOs showed cilia via TEM, acetylated α-tubulin\nclose, with herniation of the abdominal organs into the chest (OMIM (Ac-αTUB), FOXJ1 and SOX2 expression (Fig. 6k and Extended Data\n142340). Consequently, fetal lungs are mechanically compressed, limit- Fig. 6h). The ciliary beating frequency (CBF) for proximal CT and CDH\ning growth of both respiratory and vascular compartments35. To test our LAFOs was shown to be within the normal physiological range using a\nplatform for disease modeling, we derived lung organoids from both AF high-speed camera (Fig. 6l and Supplementary Video 4). Finally, when\nand TF of fetuses with severe/moderate CDH-related lung hypoplasia subjected to distal differentiation, CDH organoids showed lamellar\n(Fig. 6a and Supplementary Table 1). Fluids were obtained at FETOs, bodies and expressed SFTPB (Fig. 6m). scRNA-seq found substanfrom patients not receiving steroids3,4. AFOs were derived as above; tial differences in cellular composition between differentiated and\nhowever, due to the low TF sample volume (1–3 ml) and high cell viabil- undifferentiated CDH LAFOs, compared to control LAFOs (Fig. 6n).\nity (60–75%) we omitted sorting to preserve cell numbers. Similar to CDH LAFOs/LTFOs showed decreased basal and club cell populations,\ncontrol (CT) LAFOs (Fig. 5), we successfully generated CDH AFOs from consistent with CDH models33. We detected an increased percentage\n16 AF samples (16 of 20; 80%) and CDH TF organoids (TFOs) from 7 TF of pulmonary neuroendocrine cells in CDH LAFOs in expansion and\nsamples (7 of 17; 41.2%; Fig. 6a and Extended Data Figs. 2a and 6a,b). CDH differentiation, consistent with human CDH tissue specimens and\nLAFOs and lung TFOs (LTFOs) expanded up to passage 10, manifesting animal models37,38. Notably, we revealed increased representation of\nmorphology consistent with CT LAFOs (Fig. 6b–d). PCA confirmed that AT2 cells in CDH LAFOs/LTFOs in conjunction with further differences\nall TF-derived organoids had lung identity and demonstrated clustering in proximally and distally differentiated CDH organoids. CDH LAFOs\nof CDH LAFOs/LTFOs with an associated shift from CT LAFOs (Extended did not display the expected increase in club cells following proximal\nData Fig. 6c). CDH organoids expressed NKX2-1, SOX2 and P63 lung differentiation but showed an increased deuterosomal cell fraction.\nmarkers, along with Ki67 (Fig. 6b,c,e). Notably, CDH organoids showed Last, distalized CT LAFOs displayed an appearance of Hillock cells\nhigher SOX9 immunofluorescence positivity than CT LAFOs (Fig. 6e,f and lower airway progenitor cells, absent in distal CDH LAFOs. Of\nand Extended Data Fig. 6d), suggesting a more prominent stem/pro- note, and in contrast, distalized CDH LTFOs displayed fewer basal cells\ngenitor identity36. CDH LAFOs/LTFOs were generated from samples (Fig. 6n).\ntaken at the two FETO-related interventions: (1) occlusive endotracheal\nballoon insertion (28–31 weeks GA); and (2) balloon removal (32–34 Discussion\nweeks GA; Extended Data Fig. 6e). Paired analysis was not possible This work demonstrates that the AF contains tissue-specific fetal epidue to limited sample availability and therefore pooled analysis was thelial progenitor cells originating from various developing organs. We\nperformed. Our RNA-seq data (n = 30 CDH LAFOs from eight patients, show that, under defined culture conditions, these cells form epithelial\nn = 23 CDH LTFOs from four patients) highlighted expression of lung organoids resembling their tissues of origin (small intestine, kidney and\nepithelial stem/progenitor markers at levels similar to GA-matched CT lung). Finally, we provide evidence that lung organoids derived from\nLAFOs (Fig. 6g and Extended Data Fig. 7). SOX9 expression was remark- AF and TF of fetuses affected by CDH exhibit features of the disease.\nably downregulated in CDH organoids generated post-FETO, consist- Personalized therapeutic modeling of congenital conditions\nent with increased tissue maturation (Fig. 6h). Comparative analysis must be implemented prenatally. Here, we demonstrate derivation of\n\nfrom CDH pregnancies. a, Schematic of AF/TF sampling from CDH pregnancies. lung-associated markers are labeled. The blue dots represent the statistically\nb,c, Phase-contrast images depicting CDH LAFOs (b) and LTFOs (c) P0–P10 significant downregulated genes, and the red dots represent the statistically\n(scale bars, 200 μm). IF staining panel highlights proliferative marker Ki67, significant upregulated genes. LFC, log fold change. j, Immunofluorescent\nlung stem/progenitor markers NKX2-1/SOX2 and basal cell marker P63 in CDH staining showing pro-surfactant protein C (proSFTPC) in CDH organoids before\norganoids (scale bars, 50 μm); nuclei counterstained with Hoechst. d, Organoid (left) and after (right) FETO (scale bars, 50 μm). k, TEM image shows proximal\nformation efficiency (organoids per live cells, n = 16 CDH AF and n = 7 CDH TF CDH LAFOs exhibiting cilia (*), confirmed with IF staining for Ac-αTUB and ciliary\nindependent samples; median and quartiles) and area of CDH AFOs versus CDH transcription factor FOXJ1; nuclei counterstained with Hoechst (scale bars,\nTFOs at isolation (n ≥ 91 organoids; median and quartiles; *P = 0.00482, unpaired 500 nm TEM, 50 μm IF). FOXJ1 quantification is presented in the bar graph (n = 5\nt-test). Bar graph displays CDH LAFO/LTFO morphologies versus controls (cystic, CDH and n = 5 CT independent biological samples, mean ± s.e.m. *P = 0.0318\ncompact, mixed; n ≥ 3 independent biological samples; median and quartiles; two-tailed unpaired t-test). l, Quantification of CBF (Hz; n ≥ 5 videos per organoid\nNS, non-significant; *P = 0.0477, two-way ANOVA with multiple comparisons). line, n = 5 CDH organoid lines, n = 4 non-CDH control LAFO lines; median and\ne, Immunofluorescent staining quantification (n = 7 CT AF, n = 4 CDH AF, n = 4 quartiles; NS, non-significant, two-tailed unpaired t-test). m, TEM imaging\nCDH TF independent samples, ≥4 organoids per sample; mean ± s.e.m.; NS, showing presence of lamellar bodies (arrows) in distalized CDH organoids (scale\nnon-significant; **P = 0.0076, ****P < 0.0001, two-way ANOVA with multiple bar, 1 μm). IF staining shows surfactant protein B (SFTPB) in distalized CDH\ncomparisons). f, IF staining showing SOX9 in CDH LAFOs/LTFOs (scale bars, LAFOs/LTFOs; nuclei counterstained with Hoechst (scale bars, 50 μm).\n50 μm). g, Dot plot of lung-related markers in CDH TFOs (29–34 GA, four n, Annotated scRNA-seq UMAPs of CDH LAFOs/LTFOs in expansion (left; 1,877\npatients) and AFOs (28–34 GA, eight patients) alongside GA-matched control cells, n = 6 organoid lines), proximal (middle left; 3,843 cells, n = 5 organoid lines)\nLAFOs (27–34 GA, three patients). h, Violin plots showing SOX9 expression and distal differentiation (middle right; 6,090 cells, n = 5 organoid lines). Stacked\nbefore and after FETO in CDH LAFOs/LTFOs compared to GA-matched control bar plot of cell types between organoid identities (%) is shown (right).\nLAFOs (median and quartiles). i, Volcano plots showing DEGs between CDH\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nautologous primary fetal organoids from AF and TF, sampled for clinical and applying established culture techniques. Fluid sampling to AFO\npurposes while allowing continuation of pregnancy. The AFO technol- characterization and expansion is implemented within 4–6 weeks, a\nogy uses widely available samples, requiring minimal manipulation timeline relevant to prenatal intervention, counseling and therapy,\n\n a b P0 P1 P10 P5\n Ki67 Nuclei NKX2-1 F-ACT SOX2 Nuclei P63 Nuclei\n CDH\n\n CDH LAFO\n c Ki67 Nuclei NKX2-1 ECAD SOX2 Nuclei P63 Nuclei\n\n CDH LTFO\n\n CDH AF: 16 of 20 patients (28–34 GA)\n CDH TF: 7 of 17 patients (29–34 GA)\n\n d CT LAFO e NS NS **** NS NS f\n 0.15\n NS\n * NS NS\n CDH LAFO\n CDH LTFO 100\n NS\n ** NS NS NS CDH LAFO CDH LTFO\n 106\n * NS NS NS NS CT LAFO SOX9 Nuclei\n Organoid area (µm2)\n\n Morphology type (%)\n Organoid formation\n\n 100 CDH LAFO\n NS NS\n\n per organoid (%)\n 75 CDH LTFO\n efficiency (%)\n\n Positive cells\n 0.10\n 75\n 105 50\n 50\n 0.05\n 25 25\n\n 104\n 0 0 0\n CDH CDH CDH CDH Cystic Compact Mixed\n\n 1\n\n X2\n\n X9\n\n 3\n\n 67\n AFO TFO AFO TFO\n\n 2-\n\n P6\n\n Ki\n SO\n\n SO\n KX\n N\n g log(CPM)\n Relative expression\n 1 0.5 0\n h SOX9\n 0 2 4 8 12 CT LAFO\n 250\n CDH LAFO\n Before FETO After FETO CDH LTFO\n\n Expression (CPM)\n Diff. Diff. 200\n SOX2\n SOX9 150\n ETV4\n ETV5 Stemness 100\n ID2\n GATA6 50\n MSX2\n NKX2−1 Progenitors\n FOXA2 0\n TP63 GA Before FETO GA After FETO\n KRT5 matched matched\n TROP2\n i\n Basal\n NGFR Before FETO After FETO\n MYCN\n 10.0\n SCGB1A1\n SCGB3A2 10 5\n Secretory SFTPC\n MUC5AC SFTPD\n SLC34A2\n MUC5B AQP5\n 0 NKX2–1\n FOXJ1\n 5 LAMP3\n SFTPB\n DNAI2 Ciliated –log10(FDR)\n –log10(FDR)\n\n HOPX\n TUBA1A\n Neuro- SLC34A2 SCGB3A2\n ASCL1 –5 ABCA3\n CHGA endocrine SFTPA1\n SFTPB\n AQP5\n HOPX Alveolar\n PDPN type 1\n AGER\n SFTPA1 180 200 16 86\n SFTPA2\n SFTPB 0 0\n SFTPC Alveolar\n SFTPD type 2\n –5 0 5 10 –3 0 3\n ABCA3\n LAMP3 LFC (1 versus 2) LFC (1 versus 2)\n SLC34A2\n MKI67\n EPCAM\n Proliferation\n Epithelium\n j CDH LAFO CDH LTFO CDH LAFO CDH LTFO\n PDGFRA Mesenchymal\n proSFTPC F-ACT\n Nuclei\n 27GA\n 27GA\n 27GA\n 30GA\n 28GA\n 28GA\n 28GA\n 28GA\n 28GA\n 28GA\n 28GA\n 29GA\n 29GA\n 29GA\n 29GA\n 29GA\n 31GA\n 31GA\n 31GA\n 31GA\n 31GA\n AF 28GA\n AF 28GA\n TF 31GA\n AF 28GA\n AF 28GA\n TF 31GA\n\n 34GA\n 34GA\n 34GA\n 34GA\n 34GA\n 34GA\n 32GA\n 34GA\n 34GA\n TF 32GA\n TF 32GA\n TF 34GA\n TF 32GA\n TF 32GA\n AF 34GA\n\n AF AF TF AF AF TF\n ctrl CDH ctrl CDH\n al\n\n al\n\n al\n\n al\n im\n\n st\n\n im\n\n st\n Di\n\n Di\n ox\n\n ox\n Pr\n\n Pr\n\n k CDH LAFO CDH LTFO FOXJ1 l m CDH LAFO CDH LTFO\n NS\n *\n cells per organoid (%)\n\n Ac-αTUB 100 16 SFTPB F-ACT\n FOXJ1 Nuclei\n Nuclei 80\n 14\n CBF (Hz)\n Proximal\n\n Positive\n\n 60\n Distal\n\n 40\n 12\n 20\n\n * 0\n CT CDH\n 10\n CT CDH\n\n n Undifferentiated Proximal Distal Quantification Cell type\n 100\n Basal Hillock−like\n Basal Hillock−like Basal Hillock−like AT2\n Basal\n 75\n Ciliated\n Percentage\n\n Progenitors Progenitors 50 Club\n Club Progenitors Club Club\n Ciliated Ciliated Ciliated Deuterosomal\n Neuro- Neuro- Neuro- 25 Hillock-like\n endocrine endocrine endocrine\n LAP LAP LAP\n AT2 AT2 AT2 LAP\n diff. diff. diff. 0 Neuroendocrine\n Deuterosomal Deuterosomal Deuterosomal\n FO\n st CD L O\n Di ist DH LA O\n\n LT O\n FO\n C L FO\n Pr xim al H AFO\n im l C T L FO\n o im D L O\n\n AT2 AT2 AT2\n Di tal CT LTF\n D lC H F\n\n F\n Pr rox C H AF\n\n a D A\n\n DH A\n al H A\n ox a C LT\n\n CDH LAFO prolif. prolif. prolif.\n C TL\n C\n D\n\n AT2 AT2 AT2\n s al\n\n CDH LTFO\n LAFO\n P\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nwith great advantages over iPS cell-dependent methods, requiring 5–9 image-based characterization, rather than RNA sequencing. Disease\nmonths to produce organoids9,10,39. modeling requires a larger CDH patient cohort for platform validation\n For this work we compiled a single-cell atlas of unperturbed human to finely model the disease and test treatments. Finally, the present\nAF. AF cells are known to be mostly epithelial, with their origin often system is limited to the epithelial compartment and cannot model\nascribed to skin, kidneys and fetal membranes40. Initial AFEpC auto- complex conditions involving, for example, mesenchymal and vasmatic annotation and reference integration attempts were unsuc- cular compartments. This might be overcome by culturing organoids\ncessful. The AF has a nonspecific ambient RNA signature and contains with mesenchymal and endothelial cells. Notably, mesenchymal and\ncells that lack adhesion and are exposed to nutrients/gas imbalances. hematopoietic cells can be isolated from AF30,59, and direct reprogram-\nMoreover, currently available fetal atlases only cover earlier gestational ming of AF cells to the endothelial lineage has been reported60. Hence,\nstages and the cells analyzed are captured within their native tissue AF can provide different cell lineages to generate more-complex preenvironment41–45 (Extended Data Fig. 1e). Our map expands on the natal models. Future work will also focus on deriving organoids for\nheterogeneity of the human AFEpC, showing these to exhibit multi- each AF-exposed tissue. As an example, we identified one AFO with\nple tissue origins being therefore distinct from previously reported placental identity, suggesting the possible presence of additional\nplacental-derived amniotic epithelial cells46,47. Within AFEpCs we iden- organoid-forming AFEpCs.\ntified gastrointestinal, renal and pulmonary epithelial stem/progeni- In conclusion, we report derivation of fetal epithelial organoids of\ntor cells. In culture, these lineage-committed progenitors generated different tissues from fetal fluids, through minimally invasive sampling.\nclonal organoids capable of long-term expansion. Remarkably, upon This is achieved from continuing pregnancies, within a GA window\nmaturation, SiAFOs, KAFOs and LAFOs acquired further tissue-specific beyond the one currently accessible from fetal tissue obtained from terdifferentiation hallmarks. mination of pregnancies. Small intestine, kidney tubule and lung AFOs\n Derivation of SiAFOs was rare, with success in only two AF samples are expandable and can be functionally matured with great potential\n(16–17 weeks GA, one obtained from a termination of pregnancy). for regenerative medicine and personalized disease modeling.\nThe occurrence of AFEpCs with intestinal progenitor features is interesting, as after the breakdown of the anal membrane (12 weeks GA), Online content\nsphincters are expected to retain the intestinal content48; however, Any methods, additional references, Nature Portfolio reporting sumcolonocytes are reported in second trimester AF49 suggesting pos- maries, source data, extended data, supplementary information,\nsible release of gastrointestinal cells later in pregnancy. Thus, SiAFOs acknowledgements, peer review information; details of author contricould find therapeutic use, for example where prenatal diagnosis of butions and competing interests; and statements of data and code availshort-bowel syndrome is made. Notably, matured SiAFOs acquired ability are available at https://doi.org/10.1038/s41591-024-02807-z.\nfurther tissue-derived small intestinal organoid hallmarks50.\n KAFOs were easily derived across all gestational ages, likely due References\nto excretion from developing kidneys29. KAFOs recapitulated tubuloid 1. Davidson, J. R. et al. Fetal body MRI and its application to fetal and\nidentity14 through expression of nephron progenitor and tubule mark- neonatal treatment: an illustrative review. Lancet Child Adolesc.\ners. Upon differentiation, KAFOs upregulated functional renal proteins Health 5, 447–458 (2021).\nsuch as AQP2, SLC12A1 and CALB1. 2. Lord, J. et al. Prenatal exome sequencing analysis in fetal structural\n LAFO derivation was frequent, due to continuous provision of anomalies detected by ultrasonography (PAGE): a cohort study.\nlung progenitors to AF via regular circulation of fluid through fetal Lancet 393, 747–757 (2019).\nlungs51, interrupted during FETO, possibly explaining the differences 3. Deprest, J. A. et al. Randomized trial of fetal surgery for moderate\nbetween CDH LAFOs and CDH LTFOs52. Current CDH patient stratifica- left diaphragmatic hernia. N. Engl. J. Med. 385, 119–129 (2021).\ntion relies on simple and reliable prenatal imaging parameters53. FETO 4. Deprest, J. A. et al. Randomized trial of fetal surgery for severe left\nis of great survival benefit to the most severely affected patients, but diaphragmatic hernia. N. Engl. J. Med. 385, 107–118 (2021).\nbetter predictive functional biomarkers are needed as 60% of treated 5. Senat, M.-V. et al. Endoscopic laser surgery versus serial\nfetuses do not survive to hospital discharge54. For instance, previous amnioreduction for severe twin-to-twin transfusion syndrome.\nwork on TF showed a different miRNA signature (miR-200) in patients N. Engl. J. Med. 351, 136–144 (2004).\nwho were responsive to the intervention; however, we could not assess 6. Adzick, N. S. et al. A randomized trial of prenatal versus postnatal\nthis in our dataset due to transforming growth factor β and BMP inhi- repair of myelomeningocele. N. Engl. J. Med. 364, 993–1004\nbition interference55. We showed that CDH LAFOs/LTFOs manifest (2011).\naltered expression of surfactant protein genes. Consistently, AT2/AT1 7. Morris, R. K. et al. Percutaneous vesicoamniotic shunting\nincrease was previously suggested as a hallmark of hypoplastic and versus conservative management for fetal lower urinary tract\nCDH lungs56,57. Our RNA-seq analyses demonstrated increased AT2 gene obstruction (PLUTO): a randomised trial. Lancet 382, 1496–1506\nexpression in CDH organoid cells compared to GA-matched controls, (2013).\nsuggesting that these manifest some disease features, supporting their 8. Takasato, M. et al. Directing human embryonic stem cell\npotential use in prenatal regenerative medicine. Future investigations differentiation towards a renal lineage generates a self-organizing\nwill determine whether there is correlation between alterations in CDH kidney. Nat. Cell Biol. 16, 118–126 (2013).\nLAFOs/LTFOs and clinical outcomes of the fluid donors. If successful, 9. Michielin, F. et al. The microfluidic environment reveals a\nAFOs could become a complementary prenatal prognostic tool. It hidden role of self-organizing extracellular matrix in hepatic\nshould be noted that AF sampling after FETO is conducted before bal- commitment and organoid formation of hiPSCs. Cell Rep. 33,\nloon removal, therefore CDH LAFOs may not reliably reflect changes 108453 (2020).\nin the fetal lung in response to FETO. CDH LTFOs that are sampled from 10. Kunisaki, S. M. et al. Human induced pluripotent stem\nthe occluded trachea will do so58. Of note, although TF sampling at the cell-derived lung organoids in an ex vivo model of the congenital\ntime of FETO is less widely applicable, this gives access to pure fetal diaphragmatic hernia fetal lung. Stem Cells Transl. Med. 10,\nlung/airway cells that produce only lung organoids. 98–114 (2021).\n Among 239 organoids sequenced, we found only one to have 11. Sachs, N. et al. Long-term expanding human airway organoids for\nan unknown phenotype (Extended Data Fig. 2e), ascribed to a non- disease modeling. EMBO J. 38, e100300 (2019).\nclonality at the picking stage. For future endeavors, optimizing AFO 12. Cindrova-Davies, T. et al. Menstrual flow as a non-invasive source\nderivation could involve cost-effective methods such as PCR and of endometrial organoids. Commun. Biol. 4, 651 (2021).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n13. Lõhmussaar, K. et al. Patient-derived organoids model cervical 34. Aran, D. et al. Reference-based analysis of lung single-cell\n tissue dynamics and viral oncogenesis in cervical cancer. Cell sequencing reveals a transitional profibrotic macrophage. Nat.\n Stem Cell 28, 1380–1396 (2021). Immunol. 20, 163–172 (2019).\n14. Schutgens, F. et al. Tubuloids derived from human adult kidney 35. Zani, A. et al. Congenital diaphragmatic hernia. Nat. Rev. Dis. Prim.\n and urine for personalized disease modeling. Nat. Biotechnol. 37, 8, 1–20 (2022).\n 303–313 (2019). 36. Nikolić, M. Z. et al. Human embryonic lung epithelial tips are\n15. Giobbe, G. G. et al. SARS-CoV-2 infection and replication in multipotent progenitors that can be expanded in vitro as\n human gastric organoids. Nat. Commun. 12, 1–14 (2021). long-term self-renewing organoids. eLife 6, e26575 (2017).\n16. Cao, K. X., Booth, A., Ourselin, S., David, A. L. & Ashcroft, R. The 37. Ijsselstijn, H., Hung, N., De Jongste, J. C., Tibboel, D. & Cutz,\n legal frameworks that govern fetal surgery in the United Kingdom, E. Calcitonin gene-related peptide expression is altered in\n European Union, and the United States. Prenat. Diagn. 38, pulmonary neuroendocrine cells in developing lungs of rats with\n 475–481 (2018). congenital diaphragmatic hernia. Am. J. Respir. Cell Mol. Biol. 19,\n17. Vergallo, G. M. Freedom of scientific research and embryo 278–285 (1998).\n protection under Italian and European Court of Human Rights’ 38. Ijsselstijn, H., Gaillard, J. L. J., De Jongste, J. C., Tibboel, D. & Cutz,\n jurisprudence. Brief European legislation overview. Eur. J. Health E. Abnormal expression of pulmonary bombesin-like peptide\n Law 28, 3–25 (2021). immunostaining cells in infants with congenital diaphragmatic\n18. Regulation of stem cell research in Europe. EuroStemCell hernia. Pediatr. Res. 42, 715–720 (1997).\n https://www.eurostemcell.org/regulation-stem-cell-research- 39. Jensen, K. B. & Little, M. H. Organoids are not organs: sources of\n europe variation and misinformation in organoid biology. Stem Cell Rep.\n19. Servick, K. Biden administration scraps human fetal tissue 18, 1255–1270 (2023).\n research restrictions. Science https://doi.org/10.1126/SCIENCE. 40. Hoehn, H. & Salk, D. Morphological and biochemical\n ABJ0479 (2021). heterogeneity of amniotic fluid cells in culture. Methods Cell Biol.\n20. McCune, J. M. & Weissman, I. L. The ban on US government 26, 11–34 (1982).\n funding research using human fetal tissues: how does this fit with 41. He, P. et al. A human fetal lung cell atlas uncovers proximal-distal\n the NIH mission to advance medical science for the benefit of the gradients of differentiation and key regulators of epithelial fates.\n citizenry? Stem Cell Rep. 13, 777–786 (2019). Cell 185, 4841–4860 (2022).\n21. de Coppi, P. et al. Regenerative medicine: prenatal approaches. 42. Stewart, B. J. et al. Spatiotemporal immune zonation of the\n Lancet Child Adolesc. Health 6, 643–653 (2022). human kidney. Science 365, 1461–1466 (2019).\n22. Calà, G., Sina, B., De Coppi, P., Giobbe, G. G. & Gerli, M. F. M. 43. Hochane, M. et al. Single-cell transcriptomics reveals gene\n Primary human organoids models: current progress and key expression dynamics of human fetal kidney development. PLoS\n milestones. Front. Bioeng. Biotechnol. 11, 320 (2023). Biol. 17, e3000152 (2019).\n23. Gerrelli, D., Lisgo, S., Copp, A. J. & Lindsay, S. Enabling research 44. Wilson, S. B. et al. DevKidCC allows for robust classification and\n with human embryonic and fetal tissue resources. Development direct comparisons of kidney organoid datasets. Genome Med.\n 142, 3073–3076 (2015). 14, 1–25 (2022).\n24. Shulman, L. P. & Elias, S. Amniocentesis and chorionic villus 45. Cao, J. et al. A human cell atlas of fetal gene expression. Science\n sampling: green-top guideline No. 8 July 2021. BJOG 129, 370, eaba7721 (2020).\n 260–268 (2022). 46. Miki, T., Lehmann, T., Cai, H., Stolz, D. B. & Strom, S. C. Stem\n25. Dickinson, J. E. et al. Amnioreduction in the management of cell characteristics of amniotic epithelial cells. Stem Cells 23,\n polyhydramnios complicating singleton pregnancies. Am. J. 1549–1559 (2005).\n Obstet. Gynecol. 211, 434 (2014). 47. Parolini, O. et al. Concise review: isolation and characterization\n26. Erfani, H. et al. Amnioreduction in cases of polyhydramnios: of cells from human term placenta: outcome of the first\n indications and outcomes in singleton pregnancies without fetal international workshop on placenta derived stem cells. Stem\n interventions. Eur. J. Obstet. Gynecol. Reprod. Biol. 241, 126–128 Cells 26, 300–311 (2008).\n (2019). 48. Nievelstein, R. A. J., van der Werff, J. F. A., Verbeek, F. J., Valk, J. &\n27. Senat, M.-V. et al. Endoscopic laser surgery versus serial Vermeij-Keers, C. Normal and abnormal embryonic development\n amnioreduction for severe twin-to-twin transfusion syndrome. of the anorectum in human embryos. Teratology 57, 70–78\n N. Engl. J. Med. 351, 136–144 (2004). (1998).\n28. Underwood, M. A., Gilbert, W. M. & Sherman, M. P. Amniotic 49. Chitayat, D., Marion, R. W., Squillante, L., Kalousek, D. K. &\n fluid: not just fetal urine anymore. J. Perinatol. 25, 341–348 Das, K. M. Detection and enumeration of colonic mucosal cells\n (2005). in amniotic fluid using a colon epithelial-specific monoclonal\n29. Beall, M. H., van den Wijngaard, J. P. H. M., van Gemert, M. J. C. & antibody. Prenat. Diagn. 10, 725–732 (1990).\n Ross, M. G. Amniotic fluid water dynamics. Placenta 28, 816–823 50. Meran, L. et al. Engineering transplantable jejunal mucosal grafts\n (2007). using patient-derived organoids from children with intestinal\n30. de Coppi, P. et al. Isolation of amniotic stem cell lines with failure. Nat. Med. 26, 1593–1601 (2020).\n potential for therapy. Nat. Biotechnol. 25, 100–106 (2007). 51. Muniraman, H. Fetal lung fluid: not the same as amniotic fluid.\n31. Steigman, S. A. & Fauza, D. O. Isolation of mesenchymal stem Pediatr. Pulmonol. 56, 1270 (2021).\n cells from amniotic fluid and placenta. Curr. Protoc. Stem Cell 52. Glibert, W. M., Moore, T. R. & Brace, R. A. Amniotic fluid volume\n Biol. Chapter 1, 1E2 (2007). dynamics. Fetal Matern. Med. Rev. 3, 89–104 (1991).\n32. Ditadi, A. et al. Human and murine amniotic fluid c-Kit+Lin− 53. Davidson, J. et al. Motion corrected fetal body magnetic\n cells display hematopoietic activity. Blood 113, 3953–3960 resonance imaging provides reliable 3D lung volumes in normal\n (2009). and abnormal fetuses. Prenat. Diagn. 42, 628–635 (2022).\n33. Wagner, R. et al. A tracheal aspirate-derived airway basal cell 54. Wagner, R. et al. Proteomic profiling of hypoplastic lungs\n model reveals a proinflammatory epithelial defect in congenital suggests an underlying inflammatory response in the\n diaphragmatic hernia. Am. J. Respir. Crit. Care Med. 207, pathogenesis of abnormal lung development in congenital\n 1214–1226 (2023). diaphragmatic hernia. Ann. Surg. 278, e411–e421 (2023).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n55. Pereira-Terra, P. et al. Unique tracheal fluid microRNA signature Publisher’s note Springer Nature remains neutral with regard to\n predicts response to FETO in patients with congenital jurisdictional claims in published maps and institutional affiliations.\n diaphragmatic hernia. Ann. Surg. 262, 1130–1140 (2015).\n56. Davey, M. Surfactant levels in congenital diaphragmatic hernia. Open Access This article is licensed under a Creative Commons\n PLoS Med. 4, e243 (2007). Attribution 4.0 International License, which permits use, sharing,\n57. Donahoe, P. K., Longoni, M. & High, F. A. Polygenic causes adaptation, distribution and reproduction in any medium or format,\n of congenital diaphragmatic hernia produce common lung as long as you give appropriate credit to the original author(s) and the\n pathologies. Am. J. Pathol. 186, 2532–2543 (2016). source, provide a link to the Creative Commons licence, and indicate\n58. Evrard, V. A. et al. Intrauterine tracheal obstruction, a new if changes were made. The images or other third party material in this\n treatment for congenital diaphragmatic hernia, decreases article are included in the article’s Creative Commons licence, unless\n amniotic fluid sodium and chloride concentrations in the fetal indicated otherwise in a credit line to the material. If material is not\n lamb. Ann. Surg. 226, 753–758 (1997). included in the article’s Creative Commons licence and your intended\n59. Loukogeorgakis, S. P. & de Coppi, P. Concise review: amniotic fluid use is not permitted by statutory regulation or exceeds the permitted\n stem cells: the known, the unknown, and potential regenerative use, you will need to obtain permission directly from the copyright\n medicine applications. Stem Cells 35, 1663–1673 (2017). holder. To view a copy of this licence, visit http://creativecommons.org/\n60. Ginsberg, M. et al. Efficient direct reprogramming of mature licenses/by/4.0/.\n amniotic cells into endothelial cells by ETS factors and TGFβ\n suppression. Cell 151, 559–575 (2012). © The Author(s) 2024, corrected publication 2025\n\n1\n Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, UK. 2Great Ormond Street\nInstitute of Child Health, University College London, London, UK. 3Politecnico di Milano, Milan, Italy. 4Stem Cell and Cancer Biology Laboratory, The\nFrancis Crick Institute, London, UK. 5Armenise/Harvard Laboratory of Integrative Genomics, Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.\n6\n Elizabeth Garrett Anderson Institute for Women’s Health, University College London, London, UK. 7Department of Development and Regeneration,\nWoman and Child and UZ Leuven Clinical Department of Obstetrics and Gynaecology, KU Leuven, Leuven, Belgium. 8Department of Medical Physics and\nBiomedical Engineering, University College London, London, UK. 9Department of Radiology, Great Ormond Street Hospital, London, UK. 10Department\nof Respiratory Sciences, University of Leicester, Leicester, UK. 11Specialist Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children\nNHS Foundation Trust, London, UK. 12Department of Translational Medicine, University of Naples Federico II, Naples, Italy. 13Genomics and Experimental\nMedicine Program, Scuola Superiore Meridionale, Naples, Italy. 14Medical and Surgical Department of the Fetus, Newborn and Infant, Ospedale Pediatrico\nBambino Gesù, IRCCS, Rome, Italy. 15NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK. 16These authors contributed equally:\nMattia Francesco Maria Gerli, Giuseppe Calà. e-mail: m.gerli@ucl.ac.uk; p.decoppi@ucl.ac.uk\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nMethods Derivation and culture of human fetal LTFOs\nEthics and informed consent Euploid fetal TFs were collected during procedures of FETO carried\nFetal fluid samples were collected from all participants after written out at the UCLH or UZ Leuven (ethical approval REC 14/LO/0863 IRAS\ninformed consent in compliance with the Declaration of Helsinki. 133888 and ethics committee number S53548, respectively), kept\nEthical approval was given by the NHS Health Research Authority, in refrigerated and processed within 24–48 h. We collected TF samples\naccordance with the Governance Arrangements for Research Ethics before the insertion of the balloon (pre-FETO) and after its removal\nCommittees and complied fully with the standard operating proce- (post-FETO). Due to the nature of the TF samples, mostly small (1–3 ml)\ndures for research ethics committees in the UK. Fetal fluid samples were and containing a majority of living cells, FACS sorting was not percollected from the University College London Hospital (UCLH) Fetal formed as it was not deemed necessary. TFs were transferred into\nMaternal Unit (FMU) under the London Bloomsbury Research Ethics 15-ml tubes on ice, washed with ice-cold ADMEM+++ and centrifuged\nCommittee (REC 14/LO/0863 IRAS ID 133888) in compliance with UK at 300g for 5 min at 4 °C. Supernatant was discarded and cells were\nnational guidelines (Review of the Guidance on the Research Use of resuspended in 1 ml ADMEM+++. Cells were counted with Trypan blue\nFetuses and Fetal Material, 1989, Cm762). Fetal fluid samples were also to normalize and exclude dead cells and then plated in Matrigel (Corncollected and used at UZ Leuven (ethics committee no. S53548). Control ing, 354230) droplets as described for the AF cells above. Plates were\nfetal tissue samples were sourced via the Joint Medical Research Coun- incubated for 20 min at 37 °C and human fetal lung organoid medium\ncil (MRC)/Wellcome Trust Human Developmental Biology Resource (Supplementary Table 3) supplemented with ROCKi and Primocin\nunder informed ethical consent from all donors, undertaken with (Invivogen, NC9141851) was added. The medium was changed every 3 d.\nResearch Tissue Bank ethical approval (project 200478: UCL REC 18/ LTFOs were clonally expanded with the same methodology described\nLO/0822, IRAS ID 244325; Newcastle REC 18/NE/0290, IRAS ID 250012). above for the AFOs and passaged as described below.\nPediatric intestinal tissue sample was obtained upon informed consent\nand ethical approval for the use of human tissue obtained from the East Passaging of organoids\nof England, Cambridge Central Research Ethics Committee (REC 18/ Depending on number and size, organoids were passaged for expan-\nEE/1050). Details on recruitment and ethics oversight are also provided sion into a 24 or 12-well plate after clonal picking. Afterwards organoids\nin the Reporting Summary. were usually split 1:2 to 1:3 every 10–14 d of culture. For passaging,\n the medium was aspirated and ice-cold ADMEM+++ was added to\nAF collection and isolation of the viable cell fraction each well. Matrigel droplets were disrupted and collected into a 15-ml\nAF samples (amniocenteses and amniodrainages) were collected tube on ice. Organoids were washed with 10 ml cold ADMEM+++ and\nfrom UCLH FMU and UZ Leuven as part of standard patient clinical centrifuged at 300g for 5 min at 4 °C. Large and cystic organoids were\ncare. After collection, fluids were stored at 4 °C until processing. resuspended in 1 ml ADMEM+++ and mechanically disaggregated using\nAF samples were passed through 70-μm and 40-μm cell strainers a P1000 pipette. If small, organoids were instead disrupted enzymatiand transferred to 50-ml tubes before being centrifuged at 300g for cally as follows. The medium was aspirated and organoid pellets were\n10 min at 4 °C. Supernatant was discarded, pellet resuspended in 5–10 ml resuspended in 300 μl TrypLE. After incubation for 3–7 min at 37 °C,\nFACS blocking buffer containing 1% FBS and 0.5 mM EDTA in PBS and organoids were pipetted with P200 to break them down into single\ntransferred to FACS tubes. Cells were incubated with 5 μg ml−1 Hoechst cells. Cold ADMEM+++ was added up to 10 ml and the sample was\n(Sigma-Aldrich, 33342) for 40 min at 37 °C and then counterstained centrifuged at 300g for 5 min at 4 °C. The supernatant was discarded\nwith 2 μg ml−1 PI (Sigma-Aldrich, P4170) for 5 min at room tempera- and the cell pellet was resuspended in Matrigel (Corning, 354230) and\nture. Viable cells were sorted using a FACSAria III (BD), unselected for plated. The plate was incubated for 20 min at 37 °C to allow the Matrigel\nside and forward scatter, but gated for Hoechst+ and PI−. Viability was to solidify, upon which AFO expansion culture medium was added with\nconfirmed through a Live/Dead Acridine Orange/PI fluorescent Luna ROCKi. The medium was changed every 3 d.\ncell counter.\n Fetal tissue collection and generation of a control primary\nDerivation and culture of human AFOs fetal organoids library\nViable AF cells were resuspended in cold Matrigel (Corning, 354230) Control fetal tissue organoid derivation was conducted as follows:\nand plated at a density of 6 × 104 live cells per 30 μl droplet onto a\npre-warmed 24-well plate. Cells were cultured in an ad hoc chemically Human fetal tissue-derived small intestinal organoids. Fetal small\ndefined generic medium (AFO expansion medium; Supplementary intestines were processed as previously described61. The tissue was\nPrimocin (Invivogen, NC9141851) for the first 3 d of culture. To estab- longitudinally. The villi were scratched away using a glass coverslip.\nlish clonal organoid lines, single organoids formed at P0 (day 14–20) The remaining tissue was cut into 2–3-mm pieces, washed vigorously\nwere manually picked under the microscope to be clonally expanded. and incubated in 2 mM EDTA in PBS for 30 min for 5 min on an orbital\nEach individual organoid was assigned an ID line and transferred to shaker. The supernatant containing the intestinal crypts was centria 0.5-ml tube pre-coated with 1% BSA (Sigma-Aldrich). Organoids fuged at 800g for 5 min at 4 °C. After being washed in ADMEM+++ and\nwere resuspended in TrypLE (Thermo, 12605010) and incubated centrifuged, the pellet was resuspended in Matrigel (Corning, 354230)\nfor 5 min at 37 °C. After digestion, organoids were disaggregated by and plated in presence of Primocin (Invivogen, NC9141851) and ROCKi.\npipetting and an additional 400 μl ice-cold Advanced DMEM/F12 The recipe for the medium is in Supplementary Table 3.\nsupplemented with Glutamax, P/S and HEPES (ADMEM+++) were\nadded. Organoids were precipitated with a minicentrifuge for 2 min Human fetal tissue-derived kidney tubule organoids. The process\nand a second washing passage with ADMEM+++ was repeated. After was adapted following a previously published protocol for deriving\ncentrifugation, the pellet was resuspended in 20 μl cold Matrigel adult tubuloids14. Briefly, fetal kidneys were collected, washed in\n(Corning, 354230) and plated in a pre-warmed 48-well plate. The ice-cold HBSS and minced to isolate the cortical tissue. The tissue was\nplate was incubated for 20 min at 37 °C and AFO expansion medium washed in 10 ml basal medium and the supernatant was removed when\nwas added with ROCKi and Primocin (Invivogen, NC9141851) for the the tissue pieces settled at the bottom of the tube. After being washed\nfirst 3 d (Supplementary Table 3). Medium was replaced every 3–4 d. several times in ADMEM+++, the tubule fragments were isolated by\nAfter approximately 10–14 d, grown organoids were passaged as 1 mg ml−1 collagenase digestion (C9407, Sigma) on an orbital shaker for\ndescribed below. 30–45 min at 37 °C. Fragments were further washed in basal medium\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nwith 2% FBS and centrifuged at 300g for 5 min at 4 °C. Pellets were perimeter of each organoid in different ×5 fields acquired at the Zeiss\nresuspended in Matrigel (Corning, 354230) and cultured in kidney Axio Observer A1 and using ImageJ software. The number of formed\norganoid medium (Supplementary Table 3) supplemented with ROCKi organoids over passages was calculated by counting the organoids in\nand Primocin (Invivogen, NC9141851). each ×5 field and normalized by field size.\n\nHuman fetal tissue-derived lung organoids. Fetal lung tissue was Organoid maturation/differentiation\nprocessed by adapting a previously published protocol11. Briefly, For SiAFOs, after manual passaging, organoids were seeded in tripfetal lungs were minced and washed in ADMEM+++. Tissue fragments licate in Matrigel (Corning, 354230) and cultured in AFO expansion\nwere digested in ADMEM+++ containing 1 mg ml−1 collagenase (C9407, medium. After approximately 7 d, human small intestine medium was\nSigma) on an orbital shaker at 37 °C for 30–60 min. The digested tis- used (Supplementary Table 3) for 14 d. Basal culture medium was the\nsue was shaken vigorously and strained over a 100-μm filter. Tissue same but without the addition of CHIR99021. DAPT (Notch inhibitor)\nfragments were washed in ice-cold basal medium with 2% FBS and 10 μm was added to basal culture medium for 48 h to stimulate difcentrifuged at 300g for 5 min at 4 °C. Supernatant was discarded and ferentiation. For KAFOs, after either manual or enzymatic passaging,\npellet was resuspended in Matrigel (Corning, 354230) and cultured in organoids were seeded in triplicate in Matrigel and cultured in AFO\nlung medium (Supplementary Table 3) supplemented with ROCKi and expansion medium. After approximately 7–10 d, distal/collecting duct\nPrimocin (Invivogen, NC9141851). kidney differentiation medium (Supplementary Table 3) was used\n for 14 d62. For LAFOs, after manual passaging, organoids were seeded\nHuman fetal tissue-derived stomach organoids. Fetal stomach in triplicate in Matrigel and cultured in AFO expansion medium for\norganoids were isolated from specimens following an established approximately 10 d. For lung proximal differentiation, PneumaCult\ndissociation protocol15. Briefly, stomachs were cut open and mucus ALI Medium (Stem Cell Technologies, 05001) was used for 14 d. For\nwas removed with a glass coverslip and mucosa was stripped from distalization, organoids were exposed for 14 d to a previously reported\nmuscle layer. Mucosa samples were cut into pieces of 3–5 mm and medium63 (Supplementary Table 3).\nwashed in HBSS until the supernatant was clear. The tissue was incubated in chelating buffer supplemented with 2 mM EDTA for 30 min at Intestinal ring formation in collagen hydrogel\nroom temperature. Tissue fragments were squeezed with a glass slide The assay was adapted from a previously published protocol64. SiAFOs\nto isolate the gastric glands, which were transferred in ADMEM+++, were expanded for 7 d in AFO expansion medium. After the medium\nstrained through at 40 μm and centrifuged at 300g for 5 min at 4 °C. was removed and the wells were washed once with PBS, Matrigel drop-\nThe pellet was resuspended in Matrigel (Corning, 354230) and plated. lets were transferred to 1% BSA pre-coated Eppendorf tubes and dis-\nGastric medium (Supplementary Table 3) was added with ROCKi and solved in Cell Recovery Solution (Corning, 354253) for 45 min on ice.\nPrimocin (Invivogen, NC9141851). Organoids were centrifuged at 300g for 5 min at 4 °C and the superna-\n tant was removed. The organoids were collected and resuspended in\nHuman tissue-derived placental and fetal bladder organoids. Fetal 120 μl collagen hydrogel (collagen type I 0.75 mg ml−1, DMEM-F12 1×,\nbladder or placental biopsies were isolated and washed with ice-cold HEPES 1 M, MilliQ to volume, pH 7) and plated in an ultra-low adherent\nHBSS. Briefly, the samples were minced and washed in ADMEM+++. 24-well plate making a circular shape around the edges of the well.\nTissue fragments were digested in ADMEM+++ containing 1 mg ml−1 col- The plate was incubated for 30 min at 37 °C and medium was added\nlagenase (C9407, Sigma), 2.4 U ml−1 dispase (Thermo Fisher, 17105041) in the middle of the well to allow homogeneous detachment of the\nand 0.1 mg ml−1 DNase (Merck, 260913) on an orbital shaker at 37 °C for collagen ring. Intestinal rings were cultured in suspension in intestinal\n20–60 min. The digested tissue was then strained through at 70 μm medium for 10 d.\nfollowed by 40 μm. Tissue fragments were washed in ice-cold basal\nmedium with 10% FBS in 50-ml Falcon tubes and centrifuged at 300g Whole-mount immunofluorescence\nfor 10 min at 4 °C. The supernatant was discarded and the pellet was Before fixation, organoids were retrieved from Matrigel using Cell\nresuspended in Matrigel (Corning, 354230) and cultured in expansion Recovery Solution for 45 min on ice. Organoids were collected in a 15-ml\nmedium (Supplementary Table 3) supplemented with ROCKi and tube precoated with 1% BSA in PBS and fixed with 4% PFA for 20 min at\nPrimocin (Invivogen, NC9141851). room temperature. Samples were washed three times with PBS for 5 min\n and spun down at 300g for 5 min at 4 °C. Whole-mount immunostain-\nOrganoid cryopreservation and thawing ing was performed by blocking and permeabilizing the organoids with\nAfter 7–10 d of culture, organoids were dissociated enzymatically as PBS-Triton X-100 0.5% with 1% BSA for 1 h at room temperature. Primary\ndescribed above. The final cell pellet was resuspended in 1:1 ADMEM+++ antibodies were incubated in blocking/permeabilization buffer for 24 h\nand freezing medium (80% FBS and 20% dimethylsulfoxide). Cryovi- at 4 °C in agitation. After being extensively washed with PBS-Triton\nals were stored at −80 °C overnight and then transferred to LN2 for 0.2%, organoids were incubated with secondary antibodies and Hoelong-term storage. For organoid thawing, cryovials were equilibrated chst overnight at 4 °C in agitation. After incubation, organoids were\non dry ice and then placed at 37 °C. Vial content was rapidly transferred further washed and resuspended in PBS in preparation for confocal\nto 15-ml Falcon tubes containing 9 ml ice-cold ADMEM+++, then cen- imaging. For tissue clearing of the SiAFO ring, a previously published\ntrifuged at 300g for 5 min at 4 °C. The supernatant was discarded and protocol was adapted65. EdU staining was performed with the Click-iT\nthe pellet was resuspended in cold Matrigel (Corning, 354230). After EdU Alexa Fluor 568 Imaging kit (Life Technologies) following the\n20 min of incubation at 37 °C, the medium was supplemented with manufacturer’s protocol. A full list of antibodies is available in Sup-\nROCKi and replaced after 3 d. plementary Table 4.\n\nEvaluation of organoid formation efficiency and area Image acquisition\nOrganoid formation efficiency was determined by counting the num- Phase-contrast images were acquired using Zeiss Axio Observer A1\nber of organoids at P0. The total number of formed organoids per well and Zeiss ZEN (v.3.1) software. IF images of whole-mount staining and\nwas manually counted approximately 14 d after seeding of the AF cells sections were acquired on a Leica SP5 or a Zeiss LSM 710 confocal microin Matrigel. The efficiency was determined by calculating the total scope using ×20, ×25, ×40 and ×63 immersion objectives. Image analysis\nnumber of grown organoids divided by the number of viable single cells and z-stack projections were generated using ImageJ (https://imagej.\ninitially plated. The organoid area was determined by measuring the nih.gov/ij/). Videos of SiAFO rings were processed using Imaris (v.2).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nX-ray PC-CT performed according to the manufacturers’ instructions (F20017,\nThe imaging of the organoids was performed using PC-CT at beamline Thermo). Briefly, medium was removed and 80 µl 1× loading buffer was\nI13-1 (coherence branch) of the Diamond Light Source (www.diamond. added to each well and incubated for 30 min at room temperature and\nac.uk). The X-ray energy was 9.7 keV and the system resolution was 30 min at 37 ºC to facilitate dye entry. After removing the loading buffer,\n1.6 μm. The organoids were imaged embedded in HistoGel (Epredia 80 µl assay buffer was added to each well. A microplate reader (Soft-\nHistoGel). The PC-CT scan entailed the acquisition of 2,000 equally Max Pro v.7.1.2) was set at an excitation wavelength of 480 nm and an\nspaced projections through a 180º rotation of the specimen. The total emission wavelength of 545 nm and recorded every 5 s for 5 min. After\nscan time was approximately 1 h. The ‘single image’ phase retrieval 5 min of plate recording, voltage-gated channels were stimulated with\noperation66 was applied to the acquired projections, with the estimated 20 µl High Potassium Stimulus Buffer containing 2 mM thallium sulfate\nphase to attenuation ratio (referred to as δ:β ratio) set at 250. Both (Tl2SO4) and 10 mM potassium sulfate (K2SO4). The plate was read once\nphase retrieval and tomographic slice reconstructions were performed again every 5 s for 5 min. The average of replicates was normalized to\nusing Savu67 and 3D images were generated using Drishti68,69. the control (assay buffer) and the number of cells.\n\nmicroCT KAFO epithelial barrier integrity assay\nAfter 10 d of culture, SiAFO rings were collected and processed for Expanded KAFOs were collected in Cell Recovery Solution for 45 min\nmicroCT scanning. Rings were fixed for 1 h in 4% PFA and extensively on ice in 15-ml tubes precoated with 1% BSA. Afterwards, organoids\nwashed in PBS. The specimen was iodinated overnight by immersion in were equally divided into two tubes for the two conditions (EDTA+\n1.25% potassium triiodide in 10% formalin solution. After being rinsed and EDTA−), washed once with ADMEM+++ and centrifuged at 300g\nin deionized water, the sample was wrapped in laboratory wrapping for 5 min at 4 °C. The supernatant was removed and, to disrupt the\nfilm and mounted in HistoGel (Epredia, HG-4000-012) in a 1.5-ml tube. epithelial barrier integrity, organoids were incubated with or without\nMicroCT scanning was performed using a Nikon Med-X microCT scanner 200 µl 4 mM EDTA in PBS on ice for 15 min. Organoids were centrifuged\n(Nikon Metrology). The specimen was mounted and held in pace using a at 60g for 5 min and the EDTA solution was removed. Subsequently,\ndrill chuck to ensure centralized rotational positioning. Whole specimen 200 µl 500 µg ml−1 2–5 kDa inulin-FITC70 (Sigma, F3272) resuspended\nscans were acquired using an X-ray energy of 120 kV, current of 50 μA, in ADMEM+++ was added to both conditions. Organoids were then\nexposure time of 1,000 ms, four frames per projection, a detector gain incubated for 60 min at 37 °C and directly imaged using an LSM 710\nof 24 dB and an optimized number of projections of 2,258. A tungsten Zeiss confocal microscope. The proportion of organoids with intact\ntarget was used and an isotropic voxel size of 3.57 μm was achieved. barrier integrity (organoids without inulin signals inside the lumen)\nReconstructions were carried out using modified Feldkamp filtered back of each group was calculated for quantification analysis.\nprojection algorithms with CTPro3D (Nikon, Metrology, v.XT 5.1.43) and\npost-processed using VGStudio MAX (Volume Graphics, v.3.4). Ciliary beat frequency analysis\n Organoids were seeded into eight-well glass-bottom slides (ibidi,\nSiAFO dipeptidyl peptidase IV and disaccharidase assays 80806) and differentiated toward the lung proximal lineage for 14 d as\nFor both assays organoids were plated in 48-well plates, 15 μl basement described above. For CBF analysis, motile cilia grown inside organoids\nmembrane extract per well, in triplicate. For the dipeptidyl protease were observed using an inverted microscope system (Nikon Ti-U; Nikon\nassay, organoids were washed in PBS and then incubated at 37 °C with NIS-Elements v.5.41.02 software) with a digital high-speed video camera\n200 μl per well in Gly-Pro p-nitroanilide hydrochloride (Sigma, G0513) (Prime BSI Express, Teledyne Photometrics). Videos were recorded at\ndissolved in PBS at a concentration of 1.5 mM (or PBS alone in control a rate of approximately 178 frames per second using a ×20 objective\nwells). During incubation, samples were agitated on an orbital shaker with ×1.5 magnifier. For each subject a minimum of five organoids were\n(60 r.p.m.) and supernatants were sampled at 20, 40 and 60 min. studied. The video of each organoid was divided into 16 small regions of\nAbsorbance (415 nm) was measured with a plate reader (Bio-Rad) and interest (256 × 256) for analysis. The time taken for five full ciliary beats\nthe concentration was determined by comparison to a 4-nitroaniline was recorded. Clearly visible cilia from every small region of interest\n(Sigma, 185310) standard curve (0–200 µg ml−1) and normalized were counted for five full beats and the number of high-speed video\nper mg organoid lysate protein (Pierce BCA Protein Assay kit, Thermo frames for five full beats was noted. CBF (Hz) was calculated as (178/\nScientific). For the disaccharidase assay, basement membrane extract (number of frames for five beats)) × 5.\nwas removed by adding Cell Recovery Solution for 40 min at 4 °C and\norganoids were placed in 1.5-ml Eppendorf tubes, one well per Eppen- TEM\ndorf. Organoids were washed once in PBS and then incubated at 37 °C Organoids in the matrix were fixed in a mix of 2.5% glutaraldehyde and\nwith 200 µl per Eppendorf of 56 mM sucrose in PBS (or PBS alone for 4% paraformaldehyde in 0.1 M Sorensen’s buffer, pH 7.3, and washed\ncontrols). During incubation, samples were agitated on an orbital with 0.1 M Sorensen’s buffer. They were postfixed in 1% aqueous solushaker (60 r.p.m.). Supernatants were collected at 0, 30, 60, 90 and 120 min tion of osmium tetroxide, washed and dehydrated through an increasand sampled for glucose detection using the Amplex Red glucose/ ing series of ethanol solutions, followed by propylene oxide (Merck).\nglucose oxidase assay kit (Thermo Fisher, A22189) according to the Organoids were embedded in TAAB812 resin (TAAB Laboratory Equipmanufacturer’s protocol. Briefly, 50 µl of the reaction working solu- ment) and cut to approximately 70-nm thick sections using a Leica UC7\ntion was added to 50 µl of the test samples (diluted 1:4 with 1× reaction Ultramicrotome (Leica Microsystems). Sections were collected onto\nbuffer) in a 96-well black flat-bottom microtiter plate in duplicate and copper mesh grids and contrasted for 2 min with 4% uranyl acetate\nincubated in the dark for 30 min at room temperature. Fluorescence solution in methanol (VWR), followed by 2 min in lead citrate (Reyn-\n(excitation 535 nm and emission 590 nm) was measured using a Tecan olds’ solution). Samples were viewed on a JEOL JEM-1400 TEM ( JEOL)\nmicroplate reader (Infinite M1000 PRO). Glucose concentration was with an accelerating voltage of 120 kV. Digital images were collected\ndetermined by comparison to a glucose standard curve and normalized with a Xarosa digital camera using Radius software (both from EMSIS).\nper mg organoid lysate protein (Pierce BCA Protein Assay kit, Thermo\nScientific, 23225). Flow cytometry\n Cold-stored AF was processed as described above for viable cell sorting.\nKAFO potassium ion channel assay Viable cells were resuspended in FACS blocking buffer (FBB) and incu-\nKAFOs were expanded at least in triplicate in 96-well plates (10 µl bated for 30 min at 4 °C with the following fluorochrome-conjugated\nMatrigel per well). FluxOR II Green Potassium Ion Channel Assay was antibodies: APC/Fire 750 anti-human CD324 (E-cadherin) (BioLegend,\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n324122, 5 µl per tube), APC/Fire 750 anti-human CD326 (EpCAM) (Bio- Hoechst was used to identify nucleated cells and exclude debris; PI\nLegend, 324233, 5 µl per tube). Cells were washed in 10 ml FBB and was used to identify dead and damaged cells. Viable cells were then\nanalyzed using a BD FACSymphony A5 (BD FACSDiva v.8.0.1 software). immediately processed for cDNA library preparation. Library genera-\nData were processed on FlowJo (v.10.15). tion was conducted following the 10x Genomics Chromium Next GEM\n Single Cell 3ʹ Reagent kits v.3.1 (Dual Index). Libraries were sequenced\nRNA isolation and RT–qPCR using NovaSeq 6000. Data processing was conducted with v.6.0.1\nOrganoids were collected from Matrigel with Cell Recovery Solution for CellRanger. Ambient RNA correction was carried out with CellBender\n45 min on ice. Cells were then washed in ice-cold PBS to remove leftover v.0.2.2 on standard parameters (Broad Institute; github.com/broadin-\nMatrigel. Organoids were centrifuged at 300g for 5 min at 4 °C and the stitute/CellBender). Analysis was performed with Seurat v.4.1.1 within\nsupernatant was discarded. Pellet was resuspended and lysed with RLT a custom R script that was used for further downstream processing.\nbuffer (QIAGEN). Total RNA was isolated with an RNeasy Micro or Mini Cells with fewer than 150 features were removed to prevent doublets\nkit (QIAGEN) following the manufacturer’s instructions. RNA concen- or cells of low quality. There were 38,880 total cells and 33,934 cells\ntration was quantified using a NanoDrop (Thermo). Complementary after filtering. A single small cluster with high mitochondrial per-\nDNA was prepared using High-Capacity cDNA Reverse Transcription centage genes was removed. No cell cycle correction was carried out.\nkit (Applied Biosystems, 4368813). Quantitative real-time PCR detec- Normalization was then carried out using the NormalizeData function,\ntion was performed using PowerUp SYBR Green Master Mix (Applied with a logNormalize method and a scale factor of 10,000. Batch cor-\nBiosystems, A25742) and StepOnePlus Real-Time PCR System (Applied rection was completed through Seurat’s IntegrateData function after\nBiosystems). Assays for each sample were run in triplicate and were assessing for integration anchors based on the 2,000 most variable\nnormalized to the housekeeping gene β-actin. Primer sequences are features. The object was scaled using ScaleData, RunPCA and Findlisted in Supplementary Table 5. Neighbors determined for 20 principal components. UMAPs and violin\n plots were generated using ggplot2 and normalized gene expression\nBulk RNA sequencing was always shown, with violin plots showing averaged normalized gene\nRNA was extracted as described above and stored at −80 °C until pro- expression within the identified epithelial cluster. SingleR34 v.1.6.1 was\ncessing. NEBNext Low-Input RNA library preparation and sequencing used to label the epithelial cluster. A single-cell experiment (github.\nwere performed by the UCL genomics facility. Single-end bulk RNA com/drisso/SingleCellExperiment) object was analyzed using Human\nsequencing was conducted on an Illumina NextSeq 2000. Then, 100 Primary Cell Atlas Data (www.humancellatlas.org), accessed via celldex\ncycles were run to achieve an average of 5 million reads per sample. (github.com/LTLA/celldex). Determining the tissue of origin for the\n AFEpCs was conducted through scGSEA, using escape package v.1.12.0\nTranscriptome bioinformatics analysis (bioconductor.org/packages/escape) with the enrichIt function on\nQuality control was conducted on FASTQ raw sequences using v.0.11.9 standard parameters and the C8 cell type signature gene set from the\nFastQC (https://github.com/s-andrews/FastQC). Then, TrimGalore! Broad Institute as a reference (gsea-msigdb.org/gsea/msigdb). The\nv.0.6.6 (https://github.com/FelixKrueger/TrimGalore) was used Seurat function ModuleScore was then used to score these tissue cells\nto trim low-quality reads (quality 20 and length 70). STAR v.2.7.1a for a range of progenitor markers (‘Results’).\n(https://github.com/alexdobin/STAR) was applied to align FASTQ\nsequences to the National Center for Biotechnology Information Single-cell RNA sequencing of organoids\n(NCBI) human reference genome GRCh38.p13 (www.ncbi.nlm.nih.gov/ Organoids were expanded or differentiated according to the above\nassembly/GCF_000001405.39/). featureCounts v.1.6.3 (https://doi.org/ protocols. After washing with PBS, organoids were collected in Cell\n10.1093/bioinformatics/btt656) quantified the expression of indi- Recovery Solution for 45 min at 4 ºC for Matrigel removal and disagvidual genes to generate the raw count matrix, using the GRCh38.104 gregated to single cells by incubation with TrypLE for 7–10 min at 37 ºC.\ngene annotation (www.ensembl.org/Homo_sapiens/Info/Index). Cells were washed with FBB containing 1% FBS and 0.5 mM EDTA in\nDefault parameters were used for both alignment and quantification. PBS and centrifuged at 300g for 5 min at 4 ºC. Cells were resuspended\nThe generated count matrix was further processed with a custom R in FBB and cell viability was confirmed using a Live/Dead Acridine\nscript. Genes with fewer than ten reads across three samples were Orange/PI fluorescent Luna cell counter. Cells were prepared at 1,000\nremoved. Gene IDs were included using the added BioMart package cells per µl and cDNA library generation was completed following the\n(www.ensembl.org/info/data/biomart/biomart_r_package.html). 10x Genomics Chromium Next GEM Single Cell 3ʹ kit v.3.1 (Dual Index).\nCPM normalization was completed with the edgeR package (www. Sequencing was completed by the UCL genomics facility. Data were\nbioconductor.org/packages/release/bioc/html/edgeR.html). pre-processed using v.6.0.1 CellRanger scRNA-seq. Upon formation\n ComBat_seq batch correction (rdrr.io/bioc/sva/man/ComBat_seq. of the count matrices, analysis was continued within a custom R script\nhtml) was applied between the five batches. ggplot2 was used for graph using Seurat v.4.1.1. A total of 41 organoids were sequenced across six\ngeneration, including PCA and dot plots generated from the normal- lanes, meaning that deconvolution was required. No batch correction\nized CPM matrix. Clustered heat maps were generated with pheatmap or cell-cycle correction was carried out. Deconvolution of the data\n(cran.r-project.org/web/packages/pheatmap/) to enable hierarchical was achieved in a two-step process. Initially, single-nucleotide polycomparisons. morphism profiles were generated using CellSNP-lite v.1.2.0 from the\n For the comparison analyses, the pheatmap hierarchical clustering same AFO bulk RNA-seq data for organoids from the same samples as\nDESeq2 (bioconductor.org/packages/release/bioc/html/DESeq2.html) sequenced through scRNA-seq. The NCBI Human single-nucleotide\nwith standard parameters was used to determine DEGs. A volcano plot polymorphism dataset was used as a reference (https://ftp.ncbi.nlm.\nwas generated with ggplot2 to highlight statistically significant DEGs. nih.gov/snp/organisms/human_9606/VCF/00-common_all.vcf.gz).\nMetascape Gene Annotation and Analysis Resource v.3.5 (metascape.org) The scRNA-seq data were then deconvoluted using Vireo v.0.5.6 on a\nwas used to determine Gene Ontology pathway activation using the DEGs cell-by-cell basis. The total number of cells was 36,463. All cells not conidentified previously. A log fold change cutoff of 1 or 2 was applied as fidently assigned (as determined by Vireo) were excluded (n = 3,805,\nstated. An adjusted P value of 0.05 was used as the significance threshold. 9.8%). All barcodes identified as doublets by Vireo were removed\n (n = 5,356, 13.8%). Differentiated/mature organoids were sequenced\nscRNA-seq of AF cells in different lanes from the undifferentiated to enable separation. Cell\nViable AF cells were isolated using FACS as described above. To pre- barcode patient separations are provided as supplementary data on\nserve AF cell heterogeneity, we did not gate by forward or side scatter. the Gene Expression Omnibus. A 30% mitochondrial gene cutoff was\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\napplied to the SiAFOs but this was deemed unneeded for KAFOs or 67. Atwood, R. C., Bodey, A. J., Price, S. W. T., Basham, M. &\nLAFOs. SingleR v.1.61 was used to label epithelial cells as discussed Drakopoulos, M. A high-throughput system for high-quality\npreviously. Labeling of the different epithelial cell types present was tomographic reconstruction of large datasets at Diamond\nconducted differently for each tissue. For the SiAFO, CellTypist (www. Light Source. Philos. Trans. R. Soc. A: Math. Phys. Eng. Sci. 373,\ncelltypist.org) was used with Cells_Intestinal_Tract as input71. This was 20140398 (2015).\nperformed in conjunction with manual marker analysis to label cluster 68. Savvidis, S. et al. Monitoring tissue engineered constructs\nby cluster. For LAFOs, CellTypist was also used with three input refer- and protocols with laboratory-based X-ray phase contrast\nences: Cells_Fetal_Lung41, Cells_Lung_Airway72 and Human_Lung_Atlas73, tomography. Acta Biomater. 141, 290–299 (2022).\nin conjunction with marker analysis. KAFOs were labeled with the 69. Hu, Y., Limaye, A. & Lu, J. Three-dimensional segmentation of\nautomatic kidney-labeling tool DevKidCC (github.com/KidneyRegen- computed tomography data using Drishti Paint: new tools and\neration/DevKidCC)44, combined with marker analysis. developments. R. Soc. Open Sci. 7, 201033 (2020).\n 70. Yousef Yengej, F. A. et al. Tubuloid culture enables long-term\nStatistics and reproducibility expansion of functional human kidney tubule epithelium\nStatistical analysis was conducted on data from at least three independ- from iPSC-derived organoids. Proc. Natl Acad. Sci. USA 120,\nent experimental or biological replicates wherever possible, as stated e2216836120 (2023).\nin the figure legends. Results are expressed as mean ± s.d. or s.e.m., as 71. Elmentaite, R. et al. Cells of the human intestinal tract mapped\nthe median and quartiles (25% and 75% percentiles) or 95% CI range. across space and time. Nature 597, 250–255 (2021).\nStatistical significance was analyzed using unpaired or paired t-tests for 72. Madissoon, E. et al. A spatially resolved atlas of the human lung\ncomparisons between two different experimental groups. Statistical characterizes a gland-associated immune niche. Nat. Genet. 55,\nsignificance was assessed using one-way or two-way ANOVA with Dun- 66–77 (2022).\nnett’s, Holm–Šídák or Tukey’s multiple-comparisons test for analysis 73. Sikkema, L. et al. An integrated cell atlas of the lung in health and\namong more than two groups. *P < 0.03, **P < 0.002, ***P < 0.0002, disease. Nat. Med. 29, 1563–1577 (2023).\n****P < 0.0001 were considered significant. Exact P values are stated in\neach figure legend where appropriate. Statistical analysis was carried Acknowledgements\nout using R and GraphPad Prism v.10 software. Research at Great Ormond Street Hospital NHS Foundation Trust\n and UCL Great Ormond Street Institute of Child Health is made\nReporting summary possible by the NIHR Great Ormond Street Hospital (GOSH)\nFurther information on research design is available in the Nature Biomedical Research Centre (BRC). M.F.M.G. held an H2020 Marie\nPortfolio Reporting Summary linked to this article. Skłodowska-Curie Fellowship (843265, AmnioticID) and received\n support from the Wellcome Institutional Strategic Support Fund,\nData availability UCL Global Engagement Fund, UCL Therapeutic Acceleration\nRaw individual-level data and combined processed data of the bulk Support (TAS Call 10) and the NIHR GOSH BRC. G.C. holds a UCL\nRNA sequencing (AFOs, TFOs and fetal tissue-derived organoids) and Division of Surgery and Interventional Science PhD scholarship.\nscRNA-seq (AF and AFOs) have been uploaded to the NCBI Gene Expres- M.A.B. holds a GOSH Child Health Research Charitable Incorporated\nsion Omnibus (GSE220994). These data are openly available with no Organization (GOSH-CC) PhD Studentship. L.T. holds an NIHR GOSH\nrestriction or time limit. Questions or additional requests can be directed BRC Crick Clinical Research Training Fellowship. K.Y.S. holds a PhD\nto the corresponding authors. Source data are provided with this paper. Scholarship from Kidney Research UK (Paed_ST_005_220221129).\n J.R.D. holds an MRC Clinical Research Training Fellowship\nCode availability (MR/V006797/1). S.S. is a UKRI, EPSRC Doctoral Prize Fellow\nCode is available on Zenodo at 10.5281/zenodo.8124205. This includes R (EP/T517793/1). A.O. is supported by the Royal Academy of Engineering\nscripts used for annotation, downstream analysis and visualization. This under the Chairs in Emerging Technologies scheme (CiET1819/2/78).\ncode is openly available with no restriction or time limit. Direct questions The work of D.C. is supported by the Fondazione Telethon Core Grant,\nand additional requests can be directed to the corresponding authors. Armenise-Harvard Foundation Career Development Award, European\n Research Council (759154, CellKarma) and the Italian Ministry of\nReferences Health (Piano Operativo Salute Traiettoria 3, ‘Genomed’). J.D. is funded\n61. Giobbe, G. G. et al. Extracellular matrix hydrogel derived from by the GOSH-CC. F.M.R. is supported by a grant from My FetUZ\n decellularized tissues enables endodermal organoid culture. at KU Leuven. B.C.J. is supported by the General Sir John Monash\n Nat. Commun. 10, 1–14 (2019). Foundation as a Chairman’s Circle John Monash Scholar. A.L.D. is\n62. Uchimura, K., Wu, H., Yoshimura, Y. & Humphreys, B. D. Human supported by the UCLH BRC. V.S.W.L. is funded by the Francis Crick\n pluripotent stem cell-derived kidney organoids with improved Institute, which receives its core funding from Cancer Research UK\n collecting duct maturation and injury modeling. Cell Rep. 33, (CC2141), the UK MRC (CC2141) and the Wellcome Trust (CC2141).\n 108514 (2020). G.G.G. is supported by the UCL Therapeutic Acceleration Support\n63. Jacob, A. et al. Differentiation of human pluripotent stem cells LifeArc Fund Rare Diseases Call (TRO award no. 184646). G.G.G. and\n into functional lung alveolar epithelial cells. Cell Stem Cell 21, S.P.L. are supported by the NIHR GOSH BRC. F.M. and P.D.C. are\n 472–4880 (2017). supported by CDH-UK (16ICH03) and the BREATH Consortium\n64. Sachs, N., Tsukamoto, Y., Kujala, P., Peters, P. J. & Clevers, H. (Longfonds Voorhen Astma Fonds 552269). P.D.C. is also supported\n Intestinal epithelial organoids fuse to form self-organizing tubes by the NIHR (NIHR-RP-2014-04-046), H2020 (668294, INTENS), OAK\n in floating collagen gels. Development 144, 1107–1112 (2017). Foundation (W1095/OCAY-14-191), GOSH-CC (V5201), the Wellcome/\n65. Jafree, D. J., Long, D. A., Scambler, P. J. & Moulding, D. Tissue EPSRC Centre for Interventional and Surgical Sciences (WEISS),\n clearing and deep imaging of the kidney using confocal and two- University College London and NIHR GOSH BRC. We acknowledge\n photon microscopy. Methods Mol. Biol. 2067, 103–126 (2020). the provision of beamtime MG31437 on ID13-1 at the Diamond Light\n66. Paganin, D., Mayo, S. C., Gureyev, T. E., Miller, P. R. & Wilkins, S. W. Source. Human fetal material used for generating our control organoids\n Simultaneous phase and amplitude extraction from a single was provided by the Joint MRC/Wellcome (MR/R006237/1) Human\n defocused image of a homogeneous object. J. Microsc. 206, Developmental Biology Resource (www.hdbr.org). We are grateful to\n 33–40 (2002). A. Pellegata, M. Pellegrini, V. Karaluka, B. Crespo, A. Baulies, O. Xintarakou,\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nD. Baidya, G. Cenedese, R. Hynds, D. Jafree, D. Long, S. Mantero, A.A.S.-I. and R.A.H. generated and interpreted the TEM data. D.D.H.L.\nO.J. Arthurs, N. Elvassore, C. Pou Casellas, H. Clevers and M. Haniffa and C.O.C. conducted CBF analyses. A.L.D., F.M.R. and J.D. contributed\nfor useful discussion and advice. We are grateful to A. Eddaoudi and to fetal fluid collection and data interpretation. M.F.M.G., G.C., S.E.,\nstaff at the GOSICH Flow Cytometry facility, D. Moulding and staff G.G.G. and P.D.C. wrote the paper. All authors contributed to paper\nat the GOSICH Imaging facility, T. Brooks, P. Niola, F. Crossby and discussions and data interpretation.\nUCL Genomics. We acknowledge the UCL Myriad High Performance\nComputing Facility (Myriad@UCL) and associated support services. Competing interests\nWe acknowledge Servier Medical Art by Servier, from which we used The views expressed are those of the authors and not necessarily\nsome images licensed under a Creative Commons Attribution 3.0 those of the NHS, the NIHR or the Department of Health. The authors\nUnsupported License. We thank staff at the University of Leicester declare the following competing interests: a patent detailing the AFO\nCore Biotechnology Services Electron Microscopy Facility for help technology was filed by UCL on 18 April 2023 entitled ‘Derivation\nwith material processing. We thank the UCLH FMU research midwife of Primary Organoids from the Fetal Fluids’, under application no.\nteam, R. Devlieger, L. De Catte, L. Lewi, S. Mastrodima-Polychroniou GB2305703.7. M.F.M.G., G.G.G., P.D.C. and G.C. are listed as inventors\nand G. Attilakos who helped to collect the fluid samples. We thank on the patent. The other authors declare no competing interests.\nthe UCLH Charity and GOSH-CC for supporting the CDH FETO\nservice. Finally, we are grateful to the Human Developmental Cell Additional information\nAtlas Network, whose members provided valuable advice for the Extended data is available for this paper at\ndevelopment of the project. This publication is part of the Human https://doi.org/10.1038/s41591-024-02807-z.\nCell Atlas (www.humancellatlas.org/publications).\n Supplementary information The online version contains supplementary\nAuthor contributions material available at https://doi.org/10.1038/s41591-024-02807-z.\nM.F.M.G., G.G.G. and P.D.C. conceived the study, outlined the\nexperiments and isolated the first AFO lines. M.F.M.G. established the Correspondence and requests for materials should be addressed to\ncell-sorting methodology. G.C. supported the experimental design Mattia Francesco Maria Gerli or Paolo De Coppi.\nand conducted the main organoid culture, characterization and\nfunctional experiments with the help of B.S., K.Y.S., B.C.J., M.F.M.G. and Peer review information Nature Medicine thanks the anonymous\nG.G.G. M.A.B. performed the transcriptomic analyses with the help reviewers for their contribution to the peer review of this work.\nand support from T.X., F.P. and D.C. L.T., S.E. and V.S.W.L. contributed to Primary Handling Editor: Sonia Muliyil, in collaboration with the\nSiAFO characterization. F.M. contributed to LAFO data interpretation. Nature Medicine team.\nJ.R.D., S.E. and S.P.L. contributed to AF analyses, data interpretation\nand writing of the paper. S.S. and A.O. performed and interpreted Reprints and permissions information is available at\nX-ray PC-CT experiments. I.C.S. conducted microCT imaging analysis. www.nature.com/reprints.\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nphase-contrast image of fresh AF sample at collection (left). FACS plot showing the epithelial-labeled cluster of the scRNA-seq AF from DEGs calculated when\nheterogeneity of AF cells by forward and side scatter after sorting (right). compared to all other clusters (one-sided Fisher test, adjusted using Benjamini-\n(b) scRNA-seq UMAP analysis of n=12 AF samples; middle UMAP shows cell Hochberg for multiple hypotheses). (e) Schematic showing the comparison\ndistribution across second and third trimester; right panel shows cells labeled between the gestational age weeks covered by reference fetal scRNA-seq atlases,\nby post-conception weeks (PCW). (c) UMAPs depicting expression of epithelial highlighting the lack of late-stage development data.\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\ndepicting the workflow for clonal AFO derivation. Image created and adapted in additional AFO lines from independent patients (scale bar: 200 μm). (f) PCA\nfull licensed Biorender. (b) Phase-contrast images showing growth of clonal AFO shows all sequenced AFO with the excluded unknown sample (top); PCA showing\nfrom sorted AF epithelial cells cultured at a ratio of 5 cells in 3μL Matrigel droplet. each organoid as its gestational age (bottom). (g) Top10 pathways from gene\n(c) Percentage of samples that generated organoids at passage 0 (n=26/29 AF, ontology analysis comparing each AFO identity to the other 2 AFO identities,\nn=16/20 CDH AF, n=7/17 TF samples, mean and 95% confidence interval [AF, 72.65, (one-sided Fisher test, adjusted using Benjamini-Hochberg for multiple\n97.81; CDH AF, 56.34, 94.27; TF, 18.44, 67.08]). (d) Phase-contrast images showing hypotheses). (h) Euclidean-clustered heatmap confirming the tissue-typing\nthe recovery of AFO at passage 4 after cryopreservation and their expansion labeling of the AFO.\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nshowing SiAFOs at passage 6 and their expansion after cryopreservation until mean±SEM). (e) Stereoscopic image of an intestinal ring (scale bar: 1 mm) and\npassage 10 (scale bar: 200 μm). (b) Whole-mount immunofluorescent staining microCT images showing the presence of budding (left) as well as luminal-like\nshowing the absence of NKX2-1 (lung) and PAX8 (kidney) in SiAFO (scale bar: structures (L) (scale bars: 100 μm). (f) 3D z-stacks of SiAFO rings showing tight\n50 μm). (c) Whole-mount immunofluorescent staining for Chromogranin A junctions (ZO-1), Paneth cells (LYZ), enterocytes (FABP1 and KRT20), intestinal\n(CHGA) and Mucin 2 (MUC2) on SiAFOs in expansion medium (scale bar: 50 μm). secretory cells (MUC2) and enteroendocrine cells (CHGA); nuclei counterstained\n(d) RT–qPCR analysis of SiAFOs cultured in maturation medium without (Basal), with Hoechst (scale bars:50μm).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nshowing the thawing of KAFOs after cryopreservation at passage 7 and their assay (scale bar: 50 μm). (f) Localization of RET protein signal in fetal kidney\nexpansion until passage 10 (scale bar: 200 μm). (b) Full set of KAFOs subjected tissue slice and tissue-derived fetal kidney organoids (FKO; scale bar: 50 μm).\nto bulk RNA-seq. (c) Double positive GATA3 and LTL cells confirm a mixed (g) Distal and collecting duct markers are absent or poorly present in KAFOs in\ntubular phenotype; in the left panel a different phenotype of KAFOs was expansion medium; differentiation induces expression of CALB1, SLC12A1 and\nobserved with GATA3 positive and LTL negative cells (scale bar: 50 μm). AQP2 (n=4 independent biological samples); nuclei counterstained with Hoechst\n(d) Immunofluorescence showing presence of ZO-1-positive tight junctions in (scale bar: 50 μm).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nshowing LAFOs after cryopreservation expanded to passage 21 (Scale bar: mean±SEM, ns=non-significant, two-tailed paired t-test) (Scale bar: 50 μm).\n200 μm). (b) Different LAFO lines’ morphological phenotypes (scale bars: (g) TEM showing normal cilia rootlets with associated mitochondria (green\n200 μm), quantified in (c) (n=10 AF samples; mean with 95% CI, ***P<0.001, arrow); longitudinal section of the axonemes confirms a normal central\none-way ANOVA with multiple comparisons). (d) Full set of sequenced LAFOs. microtubule pair (yellow arrow) and radial spokes (red arrow) (scale bars:\n(e) LAFOs show absence of surfactant protein C in expansion (Scale bar: 100 nm). (h) Distalised LAFOs produce surfactant protein B vs. control in\n50 μm). (f) Airway markers (FOXJ1, ACATUB, MUC5AC, KRT5) are absent or expansion; nuclei counterstained with Hoechst (scale bars: 50 μm).\npoorly expressed at protein level in LAFOs cultured in expansion medium, but\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n(a) Comparison of organoid formation efficiency between non-CDH and CDH to GA-matched control LAFOs; red arrows highlight surfactant and matrix\nfluids at P0 (n=26 non-CDH AFs; n=16 CDH AFs; n=7 CDH TFs; median and remodeling pathways. (h) Phase-contrast image of Proximal CDH LAFOs showing\nquartiles). (b) Organoid formation efficiencies at various gestational age for cilia and mucus/debris within the lumen. Immunofluorescence image showing\nCDH AF and TF. (c) PCA showing CDH organoids alongside all the AFO clusters. Proximal CDH LAFOs expressing SOX2 (scale bars: 50 μm). (i) Ciliary beating\n(d) Representative CDH organoid lines stained for SOX9 (scale bars: 50 μm). frequency analysis of CDH organoids (n=49 organoids from 5 lines of\n(e) Derivation of CDH AFO and TFO from different patients before (left) and after 3 independent patients) vs CT LAFOs (n=40 organoids from 4 lines of\n(right) FETO surgery (scale bar: 200 μm). (f) Heatmap showing comparison of 4 independent patients; **P=0.0014 unpaired t-test).\nlung surfactant genes expression between CDH organoids before and after FETO.\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\nLAFO/LTFO. Expression of a selection of lung genes associated with different shown, with colored bars used to pair differentiated organoid with the matching\nlung cell types (log CPM). Relative expression within each gene is shown by undifferentiated organoid line. They are shown alongside GA-matched LAFO\ncolor. All CDH organoids generated, LAFO and LTFO are shown, separated by controls and tissue-derived fetal organoid controls (not age-matched).\n\nArticle https://doi.org/10.1038/s41591-024-02807-z\n\n(a) Volcano plots showing significant DEGs (p<0.05, |LFC| > 2). Lung-relevant (c) Comparison of CT LAFO between samples GA-matched to before and after\ngenes are highlighted. Comparison of organoids generated from AF or FETO (d) Comparison of LAFO with LTFO, before and after FETO. (e) DEG gene list\nTF sampled after FETO with those before FETO. (b) Comparison of LAFO and generated from comparing CDH LAFO to controls, before and after FETO.\n\n′\n\nα\n\nβ\n\nβ\n\nα\n\nμ μ\n\nμ μ",
      "rationale": "heuristic fallback",
      "detected_categories": [
        {
          "id": "cell_culture",
          "hits": 79,
          "confidence": 1.0,
          "matched_patterns": [
            "cultured",
            "culture medium",
            "incubat",
            "passage",
            "\\bwell\\b"
          ]
        },
        {
          "id": "microscopy_imaging",
          "hits": 79,
          "confidence": 1.0,
          "matched_patterns": [
            "microscop",
            "confocal",
            "fluorescen",
            "\\bimag"
          ]
        },
        {
          "id": "dna_rna_extraction",
          "hits": 37,
          "confidence": 1.0,
          "matched_patterns": [
            "lysis",
            "lysate"
          ]
        },
        {
          "id": "sequencing_library_prep",
          "hits": 29,
          "confidence": 1.0,
          "matched_patterns": [
            "sequenc",
            "illumina",
            "library"
          ]
        },
        {
          "id": "molecular_cloning",
          "hits": 21,
          "confidence": 1.0,
          "matched_patterns": [
            "clon",
            "insert",
            "transform"
          ]
        },
        {
          "id": "centrifugation",
          "hits": 16,
          "confidence": 1.0,
          "matched_patterns": [
            "centrifug"
          ]
        },
        {
          "id": "flow_cytometry",
          "hits": 9,
          "confidence": 1.0,
          "matched_patterns": [
            "flow cytometr",
            "\\bfacs\\b"
          ]
        },
        {
          "id": "pcr_qpcr",
          "hits": 8,
          "confidence": 1.0,
          "matched_patterns": [
            "\\bpcr\\b",
            "\\bq\\s*pcr\\b",
            "primer"
          ]
        }
      ],
      "split_audit": {
        "char_count": 114602,
        "word_count": 18386,
        "sentence_count": 1618,
        "category_count": 8,
        "flags": [
          "UNIT_CATEGORY_OVERMIXED"
        ]
      }
    }
  ],
  "created_at": "2026-02-17T06:45:37.859521+00:00"
}